Sommaire

• • ·Poster abstracts

    Page :i

    
• • ·Poster exhibit task force

    Page :iii

    
• • ·Table of contents

    Page :v

    
• • ·A pooled analysis of studies with a new calcipotriene/betamethasone two-compound product in psoriasis vulgaris

    Page :P1

    Alex V. Anstey, Adrian Bibby

    
• • ·Efficacy and safety of efalizumab in a large cohort of patients with moderate to severe plaque psoriasis: pooled results from randomized phase III trials

    Page :P1

    Kenneth Gordon, David Pariser, Richard Langley, Ivor Caro

    
• • ·Retrospective analysis of adverse effects and comorbidities in patients on systemic psoriasis therapy

    Page :P1

    Dan Pearce, Rajesh Balkrishnan, Wei Lang, Steven Feldman

    
• • ·Adalimumab efficacy and safety in patients with moderate to severe chronic plaque psoriasis: preliminary findings from a 12-week dose-ranging trial

    Page :P1

    Diana M. Chen, Kenneth Gordon, Craig Leonardi, M.Alan Menter

    
• • ·Alefacept in combination with tapering doses of cyclosporine in patients with psoriasis

    Page :P2

    Alice B. Gottlieb

    
• • ·The quality of life of patients with severe psoriasis treated with infliximab

    Page :P2

    Steven R. Feldman, Mohan Bala, Alan Menter, Kenneth B. Gordon

    
• • ·Efficacy of etanercept in an integrated multi-study database of patients with psoriasis

    Page :P2

    Kenneth B. Gordon, Neil Korman, Ellen Frankel, Ralph Zitnik

    
• • ·A long-term, open-label study of the safety and efficacy of oral tazarotene in moderate to very severe plaque psoriasis

    Page :P2

    Alan Menter, Deborah Lew-Kaya, Frederick Beddingfield, Patricia S. Walker

    
• • ·Long-term management with pimecrolimus cream 1% for atopic dermatitis reduces flare frequency and corticosteroid use

    Page :P3

    Elaine C. Siegfried, Neil Korman, Ken Abrams

    
• • ·Pimecrolimus cream 1% demonstrates better local tolerability than tacrolimus ointment 0.03% in pediatric patients with atopic dermatitis

    Page :P3

    Steven Kempers, Michael Jarrat, David Pariser, Eric Carter

    
• • ·Long-term efficacy and safety of TNF-alpha-inhibitor infliximab in severe atopic dermatitis

    Page :P3

    Arnd Jacobi, Gerold Schuler, Michael Hertl

    
• • ·Tacrolimus ointment 0.03 is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric and adult patients

    Page :P3

    M.Shane Chapman, Lawrence Schachner, Debra Breneman, Mark Boguniewicz

    
• • ·Systemic exposure of pimecrolimus cream 1% and tacrolimus ointment 0.1% in adult patients with moderate to severe atopic dermatitis

    Page :P4

    Zoe D Draelos, Susan Tofte, Jon Hanifin, Katie Chon

    
• • ·Semi-narrow band UV therapy for atopic dermatitis

    Page :P4

    Tokuya Omi, Seiji Kawana, Mitsuyoshi Honda, Raleigh W. Hankins

    
• • ·Acute adverse events during PUVA and narrowband UVB phototherapy: a preliminary study to establish base-line rates of adverse events

    Page :P4

    Simone Laube, Chris Edwards, Alex Anstey

    
• • ·The use of complementary medicine in patients referred for patch testing

    Page :P4

    Nicolas Nicolaou, Graham Johnston

    
• • ·Significant differences in the decision making process exist between melanoma patients who accept or decline high-dose adjuvant interferon-alpha-2B therapy

    Page :P5

    Stacey A Freedman, Tracy Bialy, Liana Abramova, Suephy Chen

    
• • ·Recurrent nodular metastatic melanoma to the placenta in a 33-year-old twin-gravida woman: a case presentation, literature review, and discussion of current therapeutic options

    Page :P5

    Gregory J. Fulchiero, Wendy L. Babitt, Catherine S. Abendroth, Harold Harvey

    
• • ·Importance of non-melanoma skin cancer as a risk factor for melanoma

    Page :P5

    Beth R Santmyire-Rosenberger, Cherie Young, Gary L. Peck

    
• • ·Diagnostic accuracy and appropriateness of management for pigmented lesions: primary care physicians and dermatologists

    Page :P5

    Michelle L Pennie, Erin Warshaw, Melanie Dixon, Suephy Chen

    
• • ·Genotype-phenotype studies in CDKN2A (p16INK4a/p14ARF) mutation positive and negative Australian high risk melanoma families

    Page :P6

    Angelo V. Sklavos, Richard F. Kefford, Dr Elizabeth. Gow, Dr Graham J. Mann

    
• • ·Reduction in melanoma mortality by a screening program at the lawrence livermore national laboratory

    Page :P6

    Jeffrey S. Schneider, Dan Moore, Mortimer Mendelsohn

    
• • ·Melanoma of unknown primary: experience at the dana farber-partners cancer center and review of the literature

    Page :P6

    Kenneth A. Katz, Eric Jonasch, F.Stephen Hodi, Frank Haluska

    
• • ·Elastic scattering spectroscopy in the diagnosis of melanocytic lesions: comparison with clinical and histopathological diagnosis

    Page :P6

    Julia J. Scarisbrick, David Pickard, Andrew Lee, Raymond Yu

    
• • ·Educational outcomes among organ transplant recipients at high risk for skin cancer-randomized intervention of intensive versus standard education

    Page :P7

    Holly E. Clowers-Webb, Leslie Christenson, Clark Otley

    
• • ·Correlation of squamous cell carcinoma invasiveness with laminin 10 expression

    Page :P7

    Keyvan Nouri, Ricardo Romogosa, Yan-Ping Zhang, Sogol Saghari

    
• • ·Correlation of embryonic fusion planes with the anatomical distribution of basal cell carcinoma

    Page :P7

    Jessica C. Newman, David Leffell

    
• • ·Imiquimod 5% cream in the treatment of multiple superficial basal cell carcinoma

    Page :P7

    Michael Freeman, Greg Siller, Shan Edwards, Mark Amies

    
• • ·Topical 0.5% fluorouracil treatment following Mohs’ surgery for squamous cell carcinoma for the prevention of future squamous cell carcinoma

    Page :P8

    Perry Robins, Elizabeth Hale

    
• • ·Impact of new immunosuppressants on the dermatological outcome of organ transplant patients

    Page :P8

    Claas Ulrich, Sylvie Euvrard, Stuart Salasche, Tobias Schmook

    
• • ·Efficacy of topical antiangiogenic therapy for basal cell and squamous cell carcinoma: a case series of 123 lesions

    Page :P8

    Sarvenaz Zand, William W. Li, Vincent W. Li

    
• • ·Skin cancer risk assessment

    Page :P8

    Anthony D. Peterson, Heather Downes, June Robinson

    
• • ·Treatment of psychodermatoses with serotonin-norepinephrine reuptake inhibitors

    Page :P9

    Sharam S Yashar, Ali Moiin

    
• • ·Mutations in fumarate hydratase cause hereditary leiomyomatosis and renal cell carcinoma in families in North America

    Page :P9

    Toro R Jorge, Berton Zbar, Maria Turner, Marston Linehan

    
• • ·Intravenous immunoglobulin therapy: effective in skin disease? a retrospective review of mayo clinic experience

    Page :P9

    Davis A. Wetter, Mark Davis, James Yiannias, Mark Dahl

    
• • ·Stressful major life events are associated with a higher prevalence of cutaneous sensory symptoms

    Page :P9

    Madhulika A Gupta, Aditya Gupta

    
• • ·Differences and similarities among expert opinions on the diagnosis and treatment of pemphigus vulgaris

    Page :P10

    Daniel Mimouni, Michael David, L. Deborah, B.S. Cummins, Grant J. Anhalt

    
• • ·Infliximab therapy in patients with severe active refractory pyoderma gangrenosum

    Page :P10

    Thor Henry Andersen, Nils-Joergen Moerk

    
• • ·Adjuvant PUVA improves duration of remission from total skin electron radiation in patients with stage IA and IB mycosis fungoides

    Page :P10

    Glenn W Jones

    
• • ·Systemic manifestations of dowling-degos disease (malignant atrophic papulosis)-update of the mayo clinic experience

    Page :P10

    Herbert C Wolfsen, Christine Ng

    
• • ·Pulse therapy with azithromycin in acne: an open study

    Page :P11

    Caputo Ruggero, Barbareschi Mauro, Veraldi Stefano

    
• • ·Evaluation of the irritancy potential of adapalene and tretinoin in volunteers of different ethnic origins

    Page :P11

    Richard S Berger, Mark Tang, Valerie Sorba, Philippe Briantais

    
• • ·Comparison of the irritation potential of five topical rosacea products

    Page :P11

    Joanne M Fraser, Michael Muscatiello, H.Irving Katz

    
• • ·The use of pyruvic acid in the treatment of acne

    Page :P11

    Alessia Pacifico, Maria Concetta Fargnoli, Angela Ferrari, Ketty Peris

    
• • ·Rosacea quality of life index (RosaQol)

    Page :P12

    Liana Abramova, Jensen Yeung, Mary Margaret Chren, Suephy Chen

    
• • ·Language disparities between patients and dermatologists in describing acne lesions

    Page :P12

    Michelle E. Lucero, Sandra Bendeck, Frances Ramos-Ceballos, Suephy Chen

    
• • ·Clinical trial patients’ topical treatment medication adherence: poor adherence or over adherence to a clinical trial regimen can adversely affect the validity of research outcomes.

    Page :P12

    Sameh S. Zaghloul, Mark Goodfield

    
• • ·Gentle and fast-acting relief from a salicylic acid acne treatment with soothing natural extracts

    Page :P12

    Dara Miller, Geoffrey Smith, Ellen S. Kurtz, Richard S. Berger

    
• • ·A double-blind comparison of the efficacy of a salicylic acid based acne treatment regimen versus a benzoyl peroxide based acne treatment regimen for the treatment of acne vulgaris

    Page :P13

    Jacobson C. Christine, Karina Arambula, Susan Chon, Alexa Kimball

    
• • ·The maintenance effect of a treatment with adapalene gel, 0.1% in patients with acne vulgaris

    Page :P13

    Jianzhong Zang, L.L. Feng, T.Y. Ting, Z. Jie

    
• • ·Clindamycin gel, 1% once a day versus clindamycin solution, 1% twice a day and clindamycin gel vehicle in the treatment of acne vulgaris

    Page :P13

    Mohsen Alirezaï, B. Gerlach, A. Horvath, D. Forsea

    
• • ·Blinded photographic review for a double blind, multicenter, placebo-controlled study comparing benzoyl peroxide/clindamycin and placebo for the treatment of rosacea

    Page :P14

    James Leyden, Diane Thiboutot, Alan Shalita

    
• • ·Evaluation of rosacea severity and facial stinging following topical application of azelaic acid 15% gel

    Page :P14

    Zoe D. Draelos

    
• • ·A multi-center investigatory study of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution

    Page :P14

    Michael H. Gold

    
• • ·A multi-center study of photodynamic therapy in the treatment of moderate to severe inflammatory acne vulgaris with topical 20% 5-aminolevulinic acid and a new intense pulsed light source

    Page :P14

    Michael H. Gold

    
• • ·The canadian acne epidemiological survey: baseline demographics and interim analysis

    Page :P15

    Jerry K.L. Tan

    
• • ·Local tolerance and sensory comparison of two topical acne gels

    Page :P15

    Alessandra Pagnoni, Joanne Fraser, Theresa Reinwald

    
• • ·Clinical improvement of refractory hidradenitis suppurativa with etanercept

    Page :P15

    Julie C. Jurgensmeyer, Alan Fleischer

    
• • ·The efficacy of violet light in the treatment of acne

    Page :P15

    Colin A. Morton, Richard Scholefield, Colin Whitehurst, Jan Birch

    
• • ·Protective effect of a broadspectrum uva-uvb sunscreen in the retinoid therapy during summer season

    Page :P16

    André M. Rougier, Hana Zelenkova, Jana Stracenska, Alain Richard

    
• • ·A clinical evaluation of the potential of a new topical acne gel for inducing irritation and contact sensitization

    Page :P16

    Joanne M. Fraser, Donald Schelling, Kays Kaidbey, Harry Klauda

    
• • ·Appearance of dark pores after extraction

    Page :P16

    Alessandra Pagnoni

    
• • ·Efficacy and safety of hydrogen peroxide cream alone or in combination with salicilyc foam in the treatment of mild-to-moderate acne

    Page :P16

    Massimo Milani, Andrea Bigardi

    
• • ·Photographic documentation of the efficacy of oral tazarotene in nodulocystic acne

    Page :P17

    James J. Leyden, Deborah Lew-Kaya, Patricia S. Walker

    
• • ·Is there evidence to necessitate prior authorization of topical retinoids: an analysis of us national practice data

    Page :P17

    Rajesh Balkrishnan, Steven Feldman, Alan Fleischer

    
• • ·A double-blind, comparative facial tolerance study of a new 10% sodium sulfacetamide & 5% sulfur aqueous gel (in a 10% urea vehicle) vs. a 10% sodium sulfacetamide & 5% sulfur topical suspension in rosacea & acne subjects with sensitive skin

    Page :P17

    James J. Leyden, Gary Grove, Charles Zerweck

    
• • ·Safety of oral tazarotene in nodulocystic acne

    Page :P17

    Nicholas J. Lowe, Deborah Lew-Kaya, Patricia S. Walker

    
• • ·Effects of oral tazarotene on health-related quality of life in patients with severe nodulocystic acne: results from a phase ii dose-ranging study

    Page :P18

    Jonathan W Kowalski, James J Leyden, Jerry Tan, Walker Patricia

    
• • ·An open study comparing efficacy of sodium 5% L-ascorbyl-2-phosphate lotion versus 5% benzoylperoxide cream in the treatment of acne vulgaris

    Page :P18

    Hiroshi Ikeno, Kitaro Ohmori, Tomoyuki Monma

    
• • ·Efficacy and safety of combination therapy of hydrogen peroxide cream and adapalene gel in comparison with benzoyl peroxide cream and adapalene in common acne

    Page :P18

    Rodolfo Capizzi, Massimo Milani

    
• • ·Evaluating the pharmacology of antimicrobial agents in acne therapy

    Page :P18

    Otto H Mills, Ronald Rizer, Robert Berger

    
• • ·Efficacy and safety of a new salicylic acid derivative as a complement of vitamin a acid in acne treatment

    Page :P19

    Andre M Rougier, Alain Richard

    
• • ·Is early rosacea distinguishable from the effects of weathering on facial skin?

    Page :P19

    Ronald Marks

    
• • ·Nudging acne by topical beta-lipohydroxy acid (LHA), a new comedolytic agent

    Page :P19

    Andre M Rougier, Gérald Pierard

    
• • ·Interest of a new salicylic acid derivative in the prevention of acne relapses

    Page :P19

    André M Rougier, Brigitte Dreno, Anne Khammari, Alain Richard

    
• • ·Assessing views of female patients regarding oral contraceptives for treatment of acne

    Page :P20

    Khondker K Islam, Moneera Haque, Rana Sokhi, Ravi Kondaveeti

    
• • ·Early-onset acne: classification and risk of virilizing endocrinopathy in 27 children

    Page :P20

    Alanna F Bree, Elaine Siegfried

    
• • ·Improved efficacy and tolerability of retinoic acid in acne vulgaris

    Page :P20

    Rana F Yavużer (Anadolu), Tangül Sen, Nilüfer Tarımcı, Ahu Birol

    
• • ·Oral tazarotene reduces comedones

    Page :P20

    Jerry K.L. Tan, Deborah Lew-Kaya, Patricia S. Walker

    
• • ·An in vitro kill rate study against p. acnes comparing four benzoyl peroxide washes

    Page :P21

    Patricia M Savoie, Nadia Whitbeck, Joanne Fraser

    
• • ·New methods for evaluating inflammatory acne dynamics

    Page :P21

    Jeannette Fong, Georgios Stamatas, Roderico Estanislao

    
• • ·Use of superficial glycolic acid chemical peelsfor varied indications in darker racial ethnic skin types

    Page :P21

    Mukta B Sachdev

    
• • ·Absorption of clindamycin from a new topical acne gel after “maximum practicable application” in patients

    Page :P21

    Angus E Donald, Jackie A Slipper, Peter J Groom, Philip R Robinson

    
• • ·The efficacy and safety of adapalene gel, 0.3% in acne: a dose ranging study

    Page :P22

    Michael Graeber, E Tschen, D Wilson, T Jones

    
• • ·Improving mild to moderate acne among asians Fitzpatrick type IV to V-through naturals

    Page :P22

    Vaishali Bhide, Anna Gomes, Roderico Estanislao, Carlos Galzotte

    
• • ·Acne theatricalus

    Page :P22

    Otto H Mills, Arnold Klein, Thomas Stephens, Ronald Rizer

    
• • ·Efficacy and safety of adapalene gel, 0.3% in acne vulgaris

    Page :P22

    H.W.A. Joyce, S Maddin, D Thiboutot, D.A. Whiting

    
• • ·The safety and efficacy of clindamycin (1% as clindamycin phosphate and tretinoin (0.025%)] for the treatment of acne vulgaris: a combined analysis of results from six controlled safety and efficacy trials conducted in Europe

    Page :P23

    Alex Yaroshinsky, James Leyden

    
• • ·Rapid acne resolution by a 2% salicylic acid gel containing a complex of naturals

    Page :P23

    Yohini Appa, Aida Asuncion, Theresa Chen, Thomas J. Stephens

    
• • ·Synergistic effect of natural actives in better and faster resolution of mild to moderate acne vulgaris in Asians Fitzpatrick type IV to V

    Page :P23

    Vaishali Bhide, Anna Gomes, Noble Mathew, Alain Khaiat

    
• • ·Cost-effectiveness of tazarotene 0.1% cream versus adapalene 0.1% cream for the treatment of facial acne vulgaris

    Page :P23

    Jeffrey T Lee, Jonathan Kowalski, Arliene Ravelo

    
• • ·Topical tazarotene meta-analysis in acne vulgaris

    Page :P24

    James J. Leyden, Nicholas Lowe, Alan Shalita, Guy Webster

    
• • ·Clindamycin phosphate foam, 1%, versus clindamycin phosphate gel, 1%, for the treatment of acne vulgaris; results of a phase III study

    Page :P24

    Judith A. Myers, Mary Spellman, Alex Yaroshinsky, Alan Shalita

    
• • ·Compatibility of two skincare regimens with an encapsulated tretinoin (0.1%) for topical treatment of acne vulgaris

    Page :P24

    Theresa Chen, Harold L. Saferstein, Wanda M. Boote, Yohini Appa

    
• • ·Clinical assessment of a salicylic acid formulation containing a complex of naturals for the treatment of acne vulgaris in Asian subjects

    Page :P24

    Carlos Galzotte, Jin Ho Chung, Aida Asuncion, Yohini Appa

    
• • ·Clinical evaluation of salicylic acid scrub, toner and mask in reducing blackheads

    Page :P25

    Alessandra Pagnoni, Theresa Chen, Huayi Dong, I-Ting Wu

    
• • ·Anti-aging therapeutic agents

    Page :P25

    Janine D Miller

    
• • ·Phase II, clinical evaluation of 2% polyphenone (green tea extract) in a hydrophilic gel to assess improvement in damaged and premature aged facial skin. a placebo-controlled, double-blind study

    Page :P25

    Tanweer A Syed, Wendy H. Wong, Seyed Ali Ahmad, Raza Aly

    
• • ·Evaluation of a d-alpha-tocopherol containing topical emulsion in dermatoheliosis. A randomized, double blind, lateral contralateral, placebo controlled trial

    Page :P25

    Rui C Tavares-Bello, Leonor Girão, Paulo Ferreira, Joselda Pires

    
• • ·Total soy to diminish wrinkles and hyperpigmentation in photoaged population

    Page :P26

    Jeff Wu, Skillman NJ, Nikiforos Kollias, Jue-Chen Liu, James Leiden

    
• • ·A placebo controlled study of an oral supplement in improving the appearance of photoaged skin

    Page :P26

    Monya L. Sigler, Thomas J. Stephens, Kit Maria Truelsen, Pernille Rasmussen

    
• • ·Validation of improved texture and elasticity measurement techniques using benchmark cosmetic and dermatological anti-aging treatments

    Page :P26

    Stacy S Hawkins, Carol Feinberg, Melissa Matzke, Ronni Weinkauf

    
• • ·Retinyl propionate and niacinamide: reduction in excess dermal GAG’s as a mechanism for their effects in improving the appearance of aging skin

    Page :P26

    Donald L Bissett, Emilia Mrowczynski, Sarah Hicks

    
• • ·Objective measurements detect early anti-aging benefits

    Page :P27

    Stacy S Hawkins, Carol Feinberg, Melissa Matzke, Ronni Weinkauf

    
• • ·Global understanding of women’s aging concerns in the eye area

    Page :P27

    Emily E Overton, Mary Troxell

    
• • ·Consumer evaluation of before and after photographs increases perception of anti-aging benefits

    Page :P27

    Stacy S Hawkins, Christine DeSantis, Melissa Matzke, Ronni Weinkauf

    
• • ·Comparison of anti-aging efficacy from cosmetic ingredients on photoaged skin

    Page :P27

    Carol Feinberg, Stacy Hawkins, Alyse Battaglia, Ronni Weinkauf

    
• • ·Open-label, split-site, pilot study of the use of Bexarotene gel 1% for the treatment of seborrheic keratoses (SKs)

    Page :P28

    Leslie Baumann, Heather Woolery-Lloyd, Lucy K. Martin, Joy M. Bryde

    
• • ·Tazarotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized, parallel-group study

    Page :P28

    Nicholas Lowe, Sewon Kang, Emil Tanghetti, Yves Poulin

    
• • ·A strange case of yaws in paris or the first case of mycosis fungoides?

    Page :P28

    Natalie M Curcio, John Zic

    
• • ·An open label pilot study evaluating the safety and efficacy of human bioengineered collagen implant in patients undergoing cutaneous correction of nasolabial folds

    Page :P28

    Leslie Baumann, Lucy K. Martin, Laura J. Black, Joy M. Bryde

    
• • ·MOHS micrographic surgery: a historical overview

    Page :P29

    Patricia T Ting, Anatoli Freiman

    
• • ·[MU]-opiate receptor system in skin and relationship to itch

    Page :P29

    Bigliardi-Qi L Paul, Bigliardi-Qi Mei, Rufli Theo, Zhou Haiyan

    
• • ·The history of biological warfare and bioterrorism: an overview

    Page :P29

    Michael K Jacobs

    
• • ·Environmental terminology in the language of dermatology

    Page :P29

    Patricia T Ting, Benjamin Barankin

    
• • ·Angiopoietin 2 in inflammation, a primary role in the invasive process?

    Page :P30

    Trevor J Markham, Ursula Fearon, Oliver FitzGerald, Douglas Veale

    
• • ·Histologic and clinical effects of topical protease application: a novel method of epidermal ablation

    Page :P30

    Howard Fein, Edward Maytin, Diya Mutasim, Philip Bailin

    
• • ·Antioxidants compared in a new protocol to measure protective capacity against oxidative stress-part II

    Page :P30

    Joseph C DiNardo, Joseph A. Lewis, Birgit A. Neudecker, Howard I. Maibach

    
• • ·P-cadherin expression in skin peeled with phenol or trichloroacetic acid (TCA)

    Page :P30

    Yuki Yamamoto, Aki Sakai, Takashi Yoshimasu, Fukumi Furukawa

    
• • ·Efficacy as used, not as tested, is true measure of sunscreen performance

    Page :P31

    Tracy L Grosick, Paul Tanner

    
• • ·Measuring skin moisturization: influence of emulsion type on test data and its implications

    Page :P31

    Teresa M Weber, Alexandra Kowcz, Ronald Rizer

    
• • ·Dermo-epidermal stimulation elicited by a salicylic acid lipophilic derivative: a comparison with salicylic acid and all trans retinoic acid

    Page :P31

    André M Rougier, Gérald Pierard, Jean Luc Leveque, Albert Kligman

    
• • ·Mechanism of action of a lipophilic salicylic acid derivative on normal skin

    Page :P31

    André M Rokugier, Jean-Luc Leveque, Gérald Pierard

    
• • ·The pore ruler: development of measurement capability for facial pores

    Page :P32

    Carol Kotkin, Kathy Lanza, Srinivasan Krishnan, Robert Velthuizen

    
• • ·Effect of retinol and anti-irritant oils on stratum corneum lipid organisation

    Page :P32

    David J. Moore, Srividya Ramakrishnan

    
• • ·Infrared spectroscopic imaging of skin

    Page :P32

    David J. Moore

    
• • ·Hormone replacement therapy (HRT) maintains skin’s lipid barrier

    Page :P32

    Manoj Misra, Carol Feinberg, Melissa Matzke, David Pocalyko

    
• • ·pH induced alterations in stratum corneum properties

    Page :P33

    David J. Moore, Steven Caso, Carol Vincent, K.P. Ananthapadmanabhan

    
• • ·Trans-cutaneous oxygen and carbon dioxide monitoring to assess topical formulation breathability

    Page :P33

    Leonora Ilardi, Vickie Foy, K. Martin, J. Rahn

    
• • ·In vivo confocal fluorescence imaging of skin surface-a novel approach to study effect of products on stratum corneum

    Page :P33

    C.Lynn Meyers, Daniel Thorn-Leeson, Kumar Subramanyan

    
• • ·Near-infrared reflectance spectroscopy and multispectral imaging detect changes in skin hydration from cleansing products

    Page :P33

    C.Lynn Meyers, Shuliang Zhang, Kumar Subramanyan, Dennis Palatini

    
• • ·Molecular diagnosis of infectious diseases in dermatology

    Page :P34

    Karan K. Sra, Katie R. Pang, Jashin J. Wu, Stephen K. Tyring

    
• • ·Sunscreen market analysis: the evolution and use of UVA-1 actives

    Page :P34

    JF Nash, Paul Tanner, Tracy Grosick, Mary Zimnawoda

    
• • ·Methods of assessing desquamation and scaliness in human skin using bioengineering techniques

    Page :P34

    Iqbal Sadiq, Tracy Stoudemayer, Albert Kligman

    
• • ·Making sensitive skin less sensitive

    Page :P34

    Tracy L Grosick, Victoria Hollis

    
• • ·Breaking the cycle of dry body skin through effective product design

    Page :P35

    Tracy L Grosick, Paul Matts, Angela Long, Colin Williamson

    
• • ·Clinical evaluation of medical skin care in korea

    Page :P35

    Hyun-Jeong Park, Jung Hoon Lee, Jun Young Lee, Baik Kee Cho

    
• • ·Vulval lymphangiomata mimicking genital warts

    Page :P35

    Khalid M Al Hawsawi, Khalid Al Aboud

    
• • ·Novel uses of infliximab in dermatology

    Page :P35

    Sarah L Jensen, Craig Leonardi

    
• • ·Broad-spectrum anti-fungal activity of pyrithione zinc and its effect on the causes of dandruff and associated itch

    Page :P36

    Thomas L Dawson, Yvonne DeAngelis, Joseph Kaczsvinsky, James Schwartz

    
• • ·Imiquimod 5% cream as a novel agent in the treatment of skin scarring

    Page :P36

    Steven D. Shapiro

    
• • ·Clinical studies to evaluate the skin tolerance and skin sensitization potential of a new antidandruff shampoo amongst sensitive skin population

    Page :P36

    Ward L Billhimer, Amy Broermann, Julie Erb, Shaoying Zhou

    
• • ·Peri-orbital dermatitis-a variant of peri-oral dermatitis

    Page :P37

    Lewis M Fiona, William Tucker

    
• • ·Highlights from the university of louisville’s clinicopathologic conference

    Page :P37

    Julie E Dixon, Jeffrey Callen

    
• • ·The use of intralesional GM-CSF in leg ulcers associated with hydroxyurea treatment in a patient with essential trombocytosis

    Page :P37

    António L. Santos, Teresa Baudrier, Nisa Freitas, Carlos Resende

    
• • ·A 7445g MTDNA mutation present in a portuguese family exhibiting hereditary deafness and palmoplantar

    Page :P37

    Maria Alexandra M.O.F. Feijóo, Rui Oliveira-Soares, João Pignatelli

    
• • ·Rud’s syndrome

    Page :P38

    Maria Concetta Fargnoli, Domenico Piccolo, Sergio A. Cuevas-Covarrubias, Ketty Peris

    
• • ·Use of imiquimod cream in the treatment of localized morphea

    Page :P38

    Marlene T. Dytoc, Jeremy Man, Janice Liao, Loretta Fiorillo

    
• • ·Development of multiple nonmelanoma skin cancers after treatment with infliximab

    Page :P38

    Adam C Esser, Andy Abril, Scott Fayne, John Doyle

    
• • ·Reticular telangiectatic erythema

    Page :P38

    Pedro Mercader, Jose Pardo-Sánchez, Mercedes Rodriguez-Serna, Jesús de la Cuadra Oyanguren

    
• • ·Carotenemia associated with increased consumption of green beans

    Page :P39

    Tanya A. Sale, Erik Stratman

    
• • ·Puzzling post-surgical papules and plaques

    Page :P39

    Shannon Heck, Frederick Quarles, Antoinette Hood

    
• • ·Acneiform eruptions caused by an epidermal growth factor receptor-tyrosine kinase inhibitor ZD 1839

    Page :P39

    Gavin A Wong, Simon Nigen, Scott Walsh, Neil Shear

    
• • ·Tazarotene 0.05% cream for the treatment of keratosis pilaris

    Page :P39

    Melissa A. Bogle, Asra Ali, Holly Bartel

    
• • ·Culinary curiosities-resemblances between common skin disorders and food

    Page :P40

    William F Tucker, Fiona Lewis

    
• • ·Destructive lupus pernio masquerading as rhinophyma in a patient with eruptive syringoma

    Page :P40

    Eileen Q. Trokhan, Hirshel Kahn, Steven Cohen

    
• • ·Topical 3% diclofenac sodium gel, a novel treatment of disseminated superficial actinic porokeratosis

    Page :P40

    Matthew W Muellenhoff, Thi Tran

    
• • ·Desquamating migratory erythema caused by nutritional deficiency-4 cases

    Page :P40

    Jonathan m.1. White, Elizabeth Higgins, Anthony du Vivier, Daniel Creamer

    
• • ·The year at parkland hospital (2004)

    Page :P41

    Whitney A High, Carrie Kovarik

    
• • ·Topical 5% imiquimod treatment for refractory cutaneous warts

    Page :P41

    Conal M Perrett, Catherine Harwood, Victoria Brown, Charlotte Proby

    
• • ·Evidence-based recommendations for recognition and diagnosis of primary focal hyperhidrosis

    Page :P41

    John C Hornberger, Hans Naver, Lewis P Stolman, Kevin Grimes

    
• • ·Plasma cell balanitis successfully treated with tacrolimus 0.1% ointment

    Page :P41

    Gerardo A Moreno-Arias, Alejandro Camps-Fresneda, Josep Palou-Almerich, Carles Llaberia

    
• • ·Efficacy of a next-generation, lipid-balanced skin repair cream for dry skin and inflammatory dermatosis

    Page :P42

    Steven D. Shapiro

    
• • ·Segmental neurofibromatosis A.K.A. neurofibromatosis type 5: antiquated terminology for a mosaic form of neurofibromatosis?

    Page :P42

    Roopal R Shanghvi, Karen Kim, Eve Lowenstein

    
• • ·Annular erythema centrifugum successfully treated with metronidazole

    Page :P42

    Lucio Andreassi, Massimiliano Risulo, Michele Fimiani, Giovambattista De Aloe

    
• • ·Extensive tuberous xanthoma

    Page :P42

    Maria G.F. Bussade, Mônica Zechmeister, Juliana H Roquini, Marcio S Rutowitsch

    
• • ·A common drug for a rare disease: treating folliculitis perforans with minocycline-case report

    Page :P43

    Natalia Mendoza, Mariam Rolon

    
• • ·Scurvy masquerading as cellulitis

    Page :P43

    Johnathon C Edge, Jeffrey Callen

    
• • ·Clinical outcome of male genital dermatoses

    Page :P43

    Manu Shah

    
• • ·Hidradenitis suppurativa: response to treatment with infliximab

    Page :P43

    Carla T Lee, Jennifer Dempsey, Jami Miller, Lloyd King

    
• • ·Acrodermatits enteropathica vs. acquired zinc deficiency

    Page :P44

    Apple A Bodemer, Rita Lloyd

    
• • ·Cutaneous leishmaniasis in children-a case series

    Page :P45

    Jennifer M Jones, Francisco Vega Lopez, Elizabeth Higgins, Jonathan Bowling

    
• • ·An unusual case of an acquired acral partial lipodystrophy associated with extrinsic allergic alveolitis

    Page :P45

    Sandra M Winhoven, Ian Coulson

    
• • ·A 20 year history of untreated multisystem langerhans cell histiocytosis

    Page :P46

    Mary Y Sheu, Lynne Morrison, Clifton White

    
• • ·Multiple flesh-colored nodules on the chin following trauma

    Page :P46

    Kelli G. Webb, Jeffrey Callen, Janine Malone, Alfred Knable

    
• • ·Linear porokeratosis treated with diclofenac sodium: a case report and review of the literature

    Page :P46

    Marya L Cassandra, Tiffany Cukrowski

    
• • ·Botryomycosis and paraneoplastic pemphigus in a 60-year-old with waldernstrom’s macroglobulinemia

    Page :P46

    Maryam Moinfar, Heidi Foster, Kimberly Bohjanen

    
• • ·Giant folliculosebaceous cystic hamartoma

    Page :P47

    Roopal V. Kundu, Sophie Worobec

    
• • ·Nonpigmented nodule on the shoulder- amelanotic congenital nevus

    Page :P47

    Jashin J. Wu, Katie R. Pang, Ida F. Orengo, Stephen K. Tyring

    
• • ·Evaluation of a sodium lactate and urea crème to ameliorate keratosis pilaris.

    Page :P47

    Teresa M Weber, Alexandra Kowcz, Ronald Rizer

    
• • ·Tropical infestations, protozoan diseases, and non-infectious tropical dermatoses

    Page :P47

    Jashin J. Wu, Katie R. Pang, Omar Lupi, Stephen K. Tyring

    
• • ·Pruritus of ILVEN relieved by topical pimecrolimus cream

    Page :P48

    Noah S. Gratch, Deng Liang, Rachelle Scott, Pai Lao

    
• • ·Combined effect of doxycycline hyclate 20 mg tablets and metronidazole 0.75% topical lotion in the treatment of rosacea

    Page :P48

    Jorge L. Sanchez, Aida Somolinos, Guy Webster, Mark Bradshaw

    
• • ·Cicatricial pemphigoid and therapy with the TNF inhibitor etanercept

    Page :P48

    Pierre G. Labrecque, Michael Null

    
• • ·Tuberculoid leprosy (Hansen’s disease) in native usa child lacking intrafamily infection

    Page :P48

    Thanh D. Nguyen, Judy O’Haver, Karen Warschaw, Ronald Hansen

    
• • ·A case of unilateral naevoid telangiectasia in association with the ovarian hyperstimulation syndrome

    Page :P49

    Judith M. Ellison

    
• • ·Sweet’s-like vasculitis induced by granulocyte colony-stimulating factor therapy in a patient with bladder carcinoma

    Page :P49

    Ilana R. Sapadin, Sumedha Lamba, Robert Phelps, Mark Lebwohl

    
• • ·Metastatic leiomyosarcoma presenting as a tender papule on the scalp

    Page :P49

    Jeffrey R. Hunek, Ethan Nydorf

    
• • ·Clincodermatopathologic highlights of jackson memorial hospital

    Page :P49

    Sharon E. Jacob, S.J. Frankel, T.S. de Araujo, G.W. Elgart

    
• • ·Study of actinic granuloma annulare in a middle-aged woman

    Page :P50

    Kristen E. Lipstreuer, Christina Hardaway

    
• • ·Quality-of-life effect of botulinum toxin type a on patients with primary axillary hyperhidrosis: results from a north american clinical study population

    Page :P50

    Jonathan W. Kowalski, Dee Anna Glaser, Nicholas J. Lowe, Arliene Ravelo

    
• • ·Botulinum toxin type a in primary axillary hyperhidrosis: a 52-week, multicenter, double-blind, randomized, placebo-controlled trial

    Page :P50

    Nicholas J. Lowe, Dee Anna Glaser, The North American BOTOX in Primary Axillary Hyperhidrosis Clinical Study Group

    
• • ·Leukodermic macules with mast cell hyperplasia: secondary reactive phenomenon or a new variant of mastocytosis?

    Page :P50

    Eve J. Lowenstein

    
• • ·Effect of pharmacologic treatment on dermatologic-specific quality of life (qol): a comparison of botulinum toxin type-a (bt-a) for primary focal hyperhidrosis (hh) to medical treatments for other dermatological diseases

    Page :P51

    James R. Spalding, Jonathan Kowalski, Jeffrey Lee, Dee Anna Glaser

    
• • ·Validity and reliability of the hyperhidrosis disease severity scale (HDSS)

    Page :P51

    Jonathan W. Kowalski, Nina Eadie, Simon Dagget, Pan-Yu Lai

    
• • ·Delayed hypersensitivity cutaneous reaction to esomeprazole-a different pattern

    Page :P51

    Ana M. Barros, Ana Cunha, Teresa Baudrier, Maria Barros

    
• • ·Generalized eruptive keratoacanthoma of grzybowski

    Page :P51

    Sate Hamza, Naveed Sami, Zlatan Oruc, Anne Bussian

    
• • ·50 Years of jessner’s lymphocytic infiltrate-a rare dermatosis revisited

    Page :P52

    Sandra M. Winhoven, Ian Coulson

    
• • ·Evidence-based recommendations for the treatment of primary axillary and palmar hyperhidrosis

    Page :P52

    D.A. Glaser, Markus Naumann, Nicholas Lowe, Multi-Specialty Working Group on the Recognition, Diagnosis, and Treatment of Primary Focal Hyperhidrosis

    
• • ·Kissing naevus of the penis: a historical and embryological review

    Page :P52

    Phuong-Anh T. Phan, Nick Francis, Christopher Bunker

    
• • ·An atypical presentation of secondary syphilis

    Page :P53

    Emily B Grossberg, Jeffrey Hunek, Marsha Chaffins

    
• • ·Patient acceptability of a new fragrance-free sulfacetamide/sulfur cleanser

    Page :P53

    Karl R. Beutner, Shawna Lemke, Janusz Czernielewski

    Résumé Résumé
• • ·Stabilized active vitamins ACE topical formulation for anti-aging-clinical investigations

    Page :P54

    Jue-Chen Liu, Jeff Wu, Nikiforos Kollias, James Leiden

    
• • ·Recurrent aphthous stomatitis: sustained remission with etanercept

    Page :P54

    Christiane Querfeld, Neha Robinson, Joan Guitart

    
• • ·Recalcitrant pruritus in two patients with idiopathic, generalized erythroderma: successful treatment with etanercept

    Page :P54

    Christiane Querfeld, Joan Guitart, Timothy Kuzel, Steven Rosen

    
• • ·Etanercept in patients with psoriatic arthritis: sustained improvement in skin and joint disease

    Page :P55

    Bernard S. Goffe, Alice Gottlieb, Mark Lebwohl, Ralph Zitnik

    
• • ·The effectiveness of etanercept in treating cutaneous sarcoidosis: a case report

    Page :P55

    Christiane Querfeld, Peter Bachmann, Joan Guitart

    
• • ·Dermal tolerability and safety of a fragrance-free sulfacetamide/sulfur cleanser

    Page :P55

    Karl R. Beutner, Shawna Lemke, Janusz Czernielewski

    
• • ·A single-blinded, placebo-controlled clinical trial evaluating the safety and efficacy of topical anesthesia with dichlorotetrafluoroethane prior to botulinum toxin type a injections for palmar hyperhidrosis

    Page :P56

    Leslie Baumann, Cindy J. Rogers, Lucy K. Martin, Laura J. Black

    
• • ·Non-invasive method for identifying pre-clinical rosacea in younger family members

    Page :P56

    Yaxian Zhen, Tracy Stoudemayer, Albert Kligman

    
• • ·Treatment of recurring cutaneous drug reactions in hiv-infected patients: a series of five cases

    Page :P56

    Jacqueline C Dolev, Ilya Reyter, Toby Maurer

    
• • ·Maffucci syndrome presenting in a patient with nail-patella syndrome

    Page :P57

    Latanya T. Benjamin, Andrea Trowers, George Elgart, Lawrence Schachner

    
• • ·Cutaneous body image: empirical validation of an important construct

    Page :P57

    Madhulika A Gupta, Aditya Gupta

    
• • ·Antiangiogenic treatment of pyogenic granuloma with imiquimod

    Page :P57

    Diego E. Marra, Harley A. Haynes, Vincent W. Li

    
• • ·Interesting cases from indiana university

    Page :P57

    Divya Railan, Charles Lewis

    
• • ·Pustular vasculitis of the hands with associated palmo-plantar pustulosis due to streptococcal hypersensitivity vasculitis

    Page :P58

    Anthony Yung, William Merchant, Robert Sheehan-Dare

    
• • ·A case of isolated cutaneous pseudo-inflammatory tumour (inflammatory myofibroblastic tumour)

    Page :P58

    Anthony Yung, William Merchant, Victoria Goulden

    
• • ·Eruptive vellus hair cysts of the forearms

    Page :P58

    Lydia A Juzych

    
• • ·Acantholytic dermatosis of the crural folds masquerading as condyloma acuminata

    Page :P58

    Adarsh V Mudgil, Paul Chu, Steve Cohen

    
• • ·Urticaria and adult-onset still’s disease

    Page :P59

    Zendee Rose M. Plateros-Elaba, Alberto Santos-Ocampo

    
• • ·Disabling pansclerotic morphea: diagnosis and progression of adult-onset disease

    Page :P59

    Sherry L Henderson, Mark Davis

    
• • ·Clinical features of periodontal ehlers-danlos syndrome (type VIII)

    Page :P59

    Sonal Shankar, Nigel Burrows

    
• • ·Tolerability and safety of combination methotrexate and alefacept in rheumatoid arthritis: results of a pilot study

    Page :P59

    Matthias Schneider, Hans-Detlev Stahl, Theresa Podrebarac, Juergen Braun

    
• • ·Alefacept in combination with methotrexate for treatment of active psoriatic arthritis: rationale and design of a randomized, double-blind, placebo-controlled study

    Page :P60

    Dafna Gladman, Edward Keystone, Alice Gottlieb

    
• • ·Pseudoxanthoma elasticum-like syndrome in a patient with sickle cell disease

    Page :P60

    Sachin S Bhardwaj, Lynn Glesne, Bruce Bart

    
• • ·Superficial venous thrombosis revealing nodous periarteritis

    Page :P60

    Ghafour Siham

    
• • ·Rheumatoid arthritis and skin disease

    Page :P60

    Effie Ladoyanni, Niki Erb, Iosif Beloukas, George Kitas

    
• • ·Objective assessment for lesion severity in atopic dermatitis

    Page :P61

    Chil-Hwan Oh, Sang-Yong Park, Sang Wook Son, Seung Han Ha

    
• • ·NC mice induced by hapten challenges as a model for atopic dermatitis and sensitive skin

    Page :P61

    Takuya Uozumi, Chiharu Kitagawa, Yuki Odake, Koji Takada

    
• • ·Evaluation of the efficacy, safety and tolerability of tacrolimus ointment in indian patients of moderate to severe atopic dermatitis

    Page :P61

    Anish A Desai, Neelesh Dongre, Chetna Ballary, D Saple

    
• • ·Assessment of quality of life and resource utilization in patients with atopic dermatitis: the rainbow study

    Page :P62

    Martin Barbeau, Gretty Deutsch, Anne-Marie Castilloux, Peter Kleinstiver

    
• • ·The effect of pimecrolimus cream 1% twice daily on pruritus in pediatric patients with mild to moderate atopic dermatitis

    Page :P62

    Joseph F Fowler, Anthony Johnson, Ken Abrams

    
• • ·The quality of life benefits of pimecrolimus cream 1% in the long-term management of mild to severe pediatric atopic dermatitis

    Page :P62

    Susan D Mathias, Kristijan H. Kahler, Farid Kianifard, Ken H. Abrams

    
• • ·Evaluation of the physical and chemical compatibility of tacrolimus ointment, 0.1% and desoximetasone ointment, 0.25%

    Page :P62

    Jacob O Levitt

    
• • ·Evaluation of efficacy and safety of desloratadine syrup in childhood atopic dermatitis

    Page :P63

    Nicola N.B. Balato, Francesca Gaudiello, Fabrizio Ayala, Fabio Ayala

    
• • ·Treatment, resources, and impact of atopic dermatitis-the triad study

    Page :P63

    Mark Boguniewicz, William Abramovits, Diane Whitaker-Worth, Amy Paller

    
• • ·Tolerance and efficacy of a moisturizing body cream for children and adults with atopic dermatitis

    Page :P63

    Teresa M Weber, Alexandra Kowcz, Ronald Rizer

    
• • ·Physical compatibility of tacrolimus ointment 0.1% with other topical medications

    Page :P63

    Jacob O Levitt, Masaru Fujiwara, Shuhei Deguchi, Teruyuki Kitagawa

    
• • ·Pimecrolimus cream 1% significantly improves atopic dermatitis in infants aged 3-23 months within 3 days of treatment

    Page :P64

    Roland Kaufmann, Regina Fölster-Holst, Peter Hoeger, Ulrich Wahn

    
• • ·Clinical evaluation in patients of a 3% lidocaine cream in an acid mantle base for the treatment of pruritus

    Page :P64

    Larry E. Millikan, Edward Coleman, Monica Trail, Ashley Counce

    
• • ·Efficacy and safety in relation to systemic exposures from orally administered pimecrolimus in patients with moderate to severe chronic plaque-type psoriasis and atopic dermatitis

    Page :P64

    Neil Shear, Alice B Gottlieb, Klaus Wolff, Robert Cherill

    
• • ·Pimecrolimus cream 1% provides effective long-term control of atopic dermatitis in infants

    Page :P65

    Kim Papp, Alexander Kapp, Mireille Ruer-Mulard, Miles J Davidson

    
• • ·Clocortolone pivalate cream 0.1% used concomitantly with tacrolimus ointment 0.1% in atopic dermatitis

    Page :P65

    Helen M Torok, Rossi Slayton

    
• • ·Patient characteristics and clinical management of atopic dermatitis-results from findings in atopic children with eczema (FACE) study

    Page :P65

    Oren Grad, Charles Hsu, Jennifer Sung, Nisha Shah

    
• • ·Impact of atopic dermatitis treatment on quality of life: results from findings in atopic children with eczema (FACE) study

    Page :P65

    Oren Grad, Neil Niren, Jennifer Sung, Amy Law

    
• • ·How does the diagnosis of latex allergy affect people’s lives?

    Page :P66

    Victoria J Lewis, Barry Statham, Mabs Chowdhury

    
• • ·Determination of incidence of dermal sensitization to a topical triple antibiotic ointment in a normal healthy population

    Page :P66

    Rita A Wanser, Kays Kaidbey, James Leyden, Bruce Kohut

    
• • ·The use of clobetasol .05% foam in the treatment of chronic hand dermatitis

    Page :P66

    J.Mark Jackson, Joseph F. Fowler

    
• • ·Determination of the cumulative irritation potential of adapalene cream and gel 0.1% compared to tretinoin micro, 0.04% and micro, 0.1% after repeated applications to the skin of healthy subjects

    Page :P66

    Jonathan S Dosik, Stéphanie Arsonnaud

    
• • ·The cumulative irritation potential of adapalene cream and gel 0.1% compared to tazarotene creams, 0.05% and 0.1% after repeated applications to the skin of healthy subjects

    Page :P67

    Jonathan S Dosik, Stéphanie Arsonnaud

    
• • ·Contact sensitivity in patients with leg ulcerations

    Page :P67

    Liliana J Saap, Simone Fahim, Emily Arsenault, Anita Pedvis-Leftick

    
• • ·Evaluation of medical grade tapes for attributes important to predictive and diagnostic testing

    Page :P67

    Stephens T Mark, Otto Mills, James Herndon

    
• • ·Use of aromatherapy products is associated with increased risk of hand dermatitis in massage therapists

    Page :P67

    Glen H. Crawford, Kenneth Katz, Elliot Ellis, William James

    
• • ·An investigation into the effect of the nitric oxide synthase antagonist L-name and plant extracts on the irritability and barrier function of the skin

    Page :P68

    Anthony David Ormerod, Pick-Ngor Woo, Jamie Islam, Marie-madeleine Cals-Grierson

    
• • ·Five years of patch testing to a dental contact battery

    Page :P68

    Megan Smith, Roger D Aldridge, Helen Horn, R Iain Macleod

    
• • ·Long-term preservation of direct immunofluorescence staining in slides stored at room termperature

    Page :P68

    Ellen O. Turner, Ronald E. Grimwood, Liana Proffer

    
• • ·Cutaneous metastases: a review of 74 cases

    Page :P68

    Pedro S Viegas, Esmeralda Vale, Isabel Viana, António Picoto

    
• • ·Great dermpath cases from South Carolina

    Page :P69

    Tammie C Ferringer, John Metcalf, Tim Smith, John Maize

    
• • ·Pseudocarcinomatous hyperplasia in the setting of CD30+VE anaplastic large cell carcinoma : a report of 2 cases

    Page :P69

    Renee H Grau, Thomas Hall, A.Neil Crowson, Sandra Clark

    
• • ·A case of isolated epidermolytic acanthoma on the neck

    Page :P69

    Bo Kyung Koh, Bo Kyung Koh, Moon Jung Choi, Jin Wou Kim

    
• • ·Expression of the human beta-defensin-2 in epidermal neoplasm drecreases the incidence of infection

    Page :P69

    John T Shen, Janet Butmarc, Evangelos Badiavas, Vincent Falanga

    
• • ·A case of giant folliculosebaceous cystic harmatoma

    Page :P70

    Hyun-Ho Park, Seok-Beom Hong, Choong-Rim Haw, Mu-Hyoung Lee

    
• • ·Benign dermal angioproliferation mimicking Kaposi’s sarcoma: report of two cases

    Page :P70

    Raashid M. Haque, Kim Carlson-Sweet, A.Neil Crowson, Raymond Cornelison

    
• • ·A case of fibrosarcomatous dermatofibrosarcoma protuberans

    Page :P70

    Heechang Choe, Yu Kyung Cho, Chul Jong Park

    
• • ·A case of Grover’s disease with syringomas like features and leukemia cutis

    Page :P70

    Garcia-Rio Irene, Aragües Maximiliano, Fraga Javier, Garcia-Diez Amaro

    
• • ·Characterizing hair loss in female patients with systemic lupus erythematosus (SLE)

    Page :P71

    Radha Mikkilineni, Paradi Mirmirani, Anita Gilliam

    
• • ·A case of dyschromatosis universalis

    Page :P71

    Latanya T. Benjamin, Andrea Trowers, George Elgart, Lawrence Schachner

    
• • ·A practical guide for the treatment of dandruff and seborrheic dermatitis

    Page :P71

    Jim R. Schwartz

    
• • ·Experimental models to investigate the efficacy and bioequivalence of low dose topical corticoids

    Page :P71

    Walter Wigger-Alberti, Dorothea Wilhelm, Stephan Bielfeldt, Klaus-Peter Wilhelm

    
• • ·Peptides for the delivery of active agents for photoaging treatment

    Page :P72

    Anneke E Andriessen

    
• • ·Pimecrolimus does not affect viability of dendritic cells, in contrast to corticosteroids

    Page :P72

    Adelheid Elbe-Buerger, Joseph Meingassner, Frank Kalthoff, Wolfram Hoetzenecker

    
• • ·Salicylic acid peeling in the treatment of rosacea

    Page :P72

    Antonella Tosti, Maria Pia de Padova, Nicola Venturo, Colombina Vincenzi

    
• • ·A corrective cosmetic cover clinic within a dermatology practice

    Page :P72

    Lee E. West, Aurora Tedeschi, Elisa Gallo, Dennis West

    
• • ·New approach for the assessment of environmental stress and its prevention

    Page :P73

    Isabelle Besne, Fanny Plismy, Christel Liviero, Philippe Catroux

    
• • ·Micro-imaging of skin with innovative methodology: valuable for skin of color

    Page :P73

    Warren Wallo, Geoffrey Smith, Michael Luedtke, Ellen S. Kurtz

    
• • ·Clinical effect of a three-day application of a commercial deodorant on axilla malodor intensity, microbial population level, and longevity of fragrance expression

    Page :P73

    Anthony C Lanzalaco, Heather Rocchetta, Sheri Gordon, Janie Kolodzik

    
• • ·Correlates of health-related quality of life in women with severe facial pigmentary disorders

    Page :P73

    Rajesh Balkrishnan, Amy McMichael, Anne Buoloc, Steven Feldman

    
• • ·Enhancement of delivery and bioavailability for drugs and cosmecueticals using amphoteric surfactants

    Page :P74

    Robert J Verdicchio, Otto Mills

    
• • ·Developing an ultra mild cleanser for sensitive skin

    Page :P74

    Kumar K Subramanyan, Anthony Johnson, Megan Bryk, Susan Krein

    
• • ·The effects of Genistein and Ginkgo Biloba on vegf expression in activated keratinocytes

    Page :P74

    Marius A Ionescu, Sandra Trompezinsky, Jacqueline Viac, Alain Denis

    
• • ·Nodular scabies in the infundibulum

    Page :P74

    Jung Hoon Lee, Min Suk Lee, Bo Kyung Koh, Jin Wou Kim

    
• • ·A new concept of acne adjuvant cosmetic: correction of sebum quality and reduction of erythromycin resistance

    Page :P75

    Ingrid Pernet, Corinne Routaboul, Michele Sayag, Alain Denis

    
• • ·Polydecene oligomers versus mineral oils: the rationale for use in dermatological preparations

    Page :P75

    Marcello Monti, Stefania Motta

    
• • ·Minocycline-tetracycline-induced severe hypertriglyceridemia in an HIV-positive patient receiving combination antiretroviral therapy

    Page :P75

    Najwa Somani, Gregory P. Bondy, Richard I. Crawford

    
• • ·Skin penetration and systemic absorption of sunscreens after topical application

    Page :P75

    Vikram Sarveiya, Stacey Risk, Heather A.E. Benson

    
• • ·Anti-aging efficacy of the combination of dimethylaminoetahnol (DMAE) and mineral salts

    Page :P76

    Thierry Oddos, Christiane Bertin, Aline Robert, Marion Fournier

    
• • ·CoQ10, a topical energizer for aging skin

    Page :P76

    Thomas Blatt, Klaus-Peter Wittern, Horst Wenck, Franz Staeb

    
• • ·A prospective, placebo-controlled, randomized, parallel group study of botulinum toxin type a for the treatment of mild to moderate platysmal bands

    Page :P76

    Fredric S. Brandt, Andres Boker

    
• • ·Suitability of cosmetic products post-microdermabrasion

    Page :P76

    Stanley B Levy, Michael Dickens, Michael Helman, John Nucci

    
• • ·Dry skin improvement by an oleosome emulsion as a carrier for sphingolipid

    Page :P77

    Daniele Marcoux, Anna Gorkiewicz-Petkow, Ranella Hirsch, Hans-Christian Korting

    
• • ·Alleviating dry, ashen skin in patients with skin of color

    Page :P77

    Judith A Nebus, Geoffry Smith, Ellen S. Kurtz, Warren Wallo

    
• • ·Clinical comparison of antiperspirant efficacy as a function of morning and/or night time application

    Page :P77

    David F. Swaile

    
• • ·The evolution of facial cleansing: substrate cleansers provide mildness benefits over leading

    Page :P77

    Sherrie L. Kinderdine, Tim Coffindaffer

    
• • ·A novel formulation in improving the appearance of post acne post inflammatory hyperpigmentation (PIH) in skin of color

    Page :P78

    Archana Sah, Thomas J. Stephens, Ellen S. Kurtz, Judith Nebus

    
• • ·Impact of corrective cosmetic use on health-related quality of life in women with severe facial pigmentary disorders

    Page :P78

    Amy J McMichael, Rajesh Balkrishnan, Anne Bouloc, Steven Feldman

    
• • ·Thalidomide: a review of new indications

    Page :P78

    Jashin J Wu, Katie R. Pang, Sylvia Hsu, Stephen K. Tyring

    
• • ·A four-month randomized, double-masked evaluation of the efficacy of botulinum toxin type a for the treatment of glabellar lines in women with skin types V and VI

    Page :P78

    Pearl E. Grimes, Maria Meraz

    
• • ·Clinical irritation patch tests of retinoid formulations

    Page :P79

    David C. Wilson, Victor Stevens

    
• • ·Simple and convenient dosing is possible with oral tazarotene

    Page :P79

    Dale Yu, Edward Lee, Patricia S. Walker, Diane Tang-Liu

    
• • ·Assessing possible synergy between a moisturizing body wash and lotion

    Page :P79

    Keith D Ertel, Paula Hartwig, Robert Bacon

    
• • ·Lymphocyte priming in murine contact hypersensitivity is affected less by pimecrolimus than by tacrolimus

    Page :P79

    Josef G Meingassner, Assadollah Bavandi, Hermann Fahrngruber, Frank Kalthoff

    
• • ·Treatment effects of 5% myristyl nicotinate on the integrity of the stratum corneum in atopic patients

    Page :P80

    Myron K Jacobson, Elaine Jacobson, Hyuntae Kim, Moonsun Kim

    
• • ·Foam as a novel vehicle in topical therapy

    Page :P80

    Helen Deng, Hanafi Tanojo, Jon Lenn, Xinfan Huang

    
• • ·Evaluation of mahonia aquifolia containing topical emulsion in the treatment of psoriasis vulgaris. A randomized, double blind, lateral-contra-lateral placebo controlled trial

    Page :P80

    Leonor Girão, Rui Tavares-Bello

    
• • ·Characteristics of the late-stage biopharmaceutical pipeline

    Page :P80

    Paul P Nagle, Timothy Lugo, Christopher Nicita

    
• • ·DMAE contributes to mildness of a facial cleanser designed for sensitive skin

    Page :P81

    James J. Leyden, Charles Zerweck, Sylvia Barkovic, Roxanne Thomas

    
• • ·Differences in facial cleanser rinsability evaluated in vivo by fourier transform infra red spectroscopy

    Page :P81

    Sidney B. Hornby, Roxanne Thomas, Yohini Appa

    
• • ·Photodynamic therapy: an overviewhotodynamic therapy: an overview

    Page :P81

    Aditya K. Gupta

    
• • ·Derivatives of sugar compounds provide anti-aging effects

    Page :P81

    Barbara A. Green, Brenda L. Edison, Richard H. Wildnauer, Robert H. Hwu

    
• • ·Predictive models for mottled hyper-pigmentation in skin using advanced image analysis and data processing methodology

    Page :P82

    Thomas M. Hancewicz, Sanjay Shirsat, Miles Eddowes

    
• • ·Asynchronous teledermatology in an urban primary care practice

    Page :P82

    Karen C. McKoy, Sharon DiGregorio, Lisa Stira

    
• • ·Preliminary study on virtual dermatological examination using mobile video phone device

    Page :P82

    Marcello Monti, Stefania Motta

    
• • ·Using the internet to enhance drug safety monitoring from phase 1 to phase 4 in dermatology clinical trials

    Page :P82

    Jules T. Mitchel, Otto Mills

    
• • ·Factors that influence a career towards academic dermatology

    Page :P83

    Jashin J Wu, Katie R. Pang, Patricia C. Lee, Stephen K. Tyring

    
• • ·Sunburns: a public health issue. The French pharmacist’s progress

    Page :P83

    Louis Dubertret, T. Nocera, J.P. Latapie, Eric Myon, Charles Taı̈eb

    
• • ·Can sun protection knowledge change behavior in a resistant population?

    Page :P83

    Julie E. Zurakowski, Jenifer Lloyd, Karen Gil

    
• • ·A perfect match: factors involved in dermatology residency applicant’s decision making

    Page :P83

    Erin M Long, Jennifer Clarke, Jennifer Sceppa, Jeffrey Miller

    
• • ·DERM (Dermatologic education for residents and medical students): a pilot program of web-based dermatologic teaching to maximize efficient use of time for residents and medical students

    Page :P84

    Smita Krishnamurthy, Julia Libecco, Eliot N. Mostow

    
• • ·Clinical inquiries from dermatologists are greater in number as compared to other medical specialties following pimecrolimus cream 1% availability in the USA market

    Page :P84

    Elisa Bauer, Katie Chon, Fran Dapas, Pablo Jimenez

    
• • ·Mentoring in dermatology

    Page :P84

    Gloria F. Graham, Amy Derrow, Vishal Khanna, Mandeep Kaur

    
• • ·Bioterrorism preparedness in the dermatology community: a brief survey study

    Page :P84

    Christie L. Carroll, Vishal Khanna, Rajesh Balkrishnan, Steven Feldman

    
• • ·The reliability of medicare claims for treatment of invasive melanoma

    Page :P85

    David A. Barzilai, Mendel Singer, Alfred Rimm, Kevin Cooper

    
• • ·Malignant melanoma epidemiology-greater victoria area 1993–96

    Page :P85

    Michelle Withers, Harvey Lui, Patrick Kenny

    
• • ·Improved resource utilization in a practice with a high indigent patient population

    Page :P85

    Kimberly A. Yeung-Yue, Rolla Abdul-Khalek, Jennifer Trepte, George Murakawa

    
• • ·Assessing the role of race in quantitative measures of skin pigmentation and clinical assessments of photosensitivity

    Page :P86

    Joanna L. Chan, Alan Moshell, Maria Turner, Alexa Kimball

    
• • ·Healthy skin 2003: significance and results of an italian study in healthy population with particular regard to “sensitive” skin

    Page :P86

    Adele Sparavigna, Antonino Di Pietro, Michele Setaro

    
• • ·Racial differences in treatment of pigmentation disorders in outpatient settings: analysis of us national practice data

    Page :P86

    Rajesh Balkrishnan, Amy McMichael, Steven Feldman, Alan Fleischer

    
• • ·Usage patterns of medical services and prescription drugs in patients with tinea capitis

    Page :P86

    Dong-Churl Suh, Hyunchul Shin, Monika Raut, Amir Tavakkol

    
• • ·Can melanoma patients predict quality of life impact of a melanoma stage different from their own?

    Page :P87

    Jason C. Hadley, Sandra Bendeck, Katherine Brown, Suephy Chen

    
• • ·Privacy attitudes among dermatology patients of color

    Page :P87

    Noah S Scheinfeld

    
• • ·African American ethnicity and anti-retroviral therapy as determinants of cutaneous photosensitivity among HIV-positive patients in a specialized dermatology clinic

    Page :P88

    Adam J. Mamelak, Ruby Nguyen, Donna Bilu, Ciro Martins

    
• • ·Utilization of topical steroids and topical immunomodulators in the United States

    Page :P88

    Sarah L. Truong, Farid Nasser, George Murakawa

    
• • ·Brooke-Spiegler syndrome: different phenotypes in a four generation family

    Page :P88

    Tiziana Surrenti, Norbert Haas, Ketty Peris, Wolfram Sterry

    
• • ·Erythropoietic protophoria: case reports at west virginia university and review of the literature

    Page :P88

    Barrett A. Louden, Amy Norton, Jeffrey Jackson

    
• • ·Cowden syndrome with proteus-like manifestations. Recurrence of secondary alterations as PTEN allelic defect in lesional skin.

    Page :P89

    Frederic Caux, Liliane Laroche, Michel Longy, Olivier Fain

    
• • ·Proteus syndrome and tuberous sclerosis: any genetic association?

    Page :P89

    Pitiporn Suwattee, Catharine Walsh, Nhung Ho

    
• • ·Darie’s disease treated with acitretin

    Page :P89

    Luna Azulay-Abulafia, Suely Bomfim, Fabricio Quintanilha, Rubem Azulay

    
• • ·Birt-Hogg-Dubé syndrome: identification of a novel gene and its clinical manifestations

    Page :P89

    Jorge R. Toro, Maria Turner, Marston Linehan, Berton Zbar

    
• • ·Central centrifugal alopecia

    Page :P90

    Nicole M. DeYampert, Angela Lamb, Susan Taylor, Elena Jones

    
• • ·The presence of pseudomonas aeruginosa in clinically suspected dermatophyte onychomycosis

    Page :P90

    Lacey M. Thomas, Boni Elewski

    
• • ·Alopecia areata in a patient using infliximab: new insights into the role of tumor necrosis factor on human hair follicles

    Page :P90

    Leila Ettefagh, Paradi Mirmirani

    
• • ·Lipedematous alopecia, a rare form of diffuse hair loss

    Page :P90

    Mohsin R. Mir, Jeffrey Jackson

    
• • ·Characterization of tiger tail banding and hair shaft abnormalities in trichothiodystrophy

    Page :P91

    Christine A. Liang, Kenneth Kraemer, Andrea Morris, John DiGiovanna

    
• • ·A one-year observational study with minoxidil 5% solution in Germany: results of independent efficacy evaluation by physicians and patients

    Page :P91

    Jan Rundegren

    
• • ·Rapid onset of action of minoxidil 5% topical solution in a 4-month German observational study on both patients and physicians

    Page :P91

    Jan Rundegren

    
• • ·Nail severity index (Naildex): burden of onychomycosis

    Page :P91

    Suephy C. Chen, Janet Wall, Erin Warshaw, Allison Hoffman

    
• • ·Analysis of serum zinc and copper levels in alopecia areata

    Page :P92

    Kyu Uang Whang, Jong Suk Lee, Sung Yul Lee, Young Lip Park

    
• • ·Effect of substance P on the human hair growth in vitro

    Page :P92

    Jin Wook Lee, Tak Heon Oh, Sanghoon Lee, Won-Soo Lee

    
• • ·Cicatricial alopecia/lichen planopilaris-the Cleveland clinic foundation experience on evaluation, diagnosis and treatment

    Page :P92

    Wilma F. Bergfeld, Berna Remzi, Nathaniel Cevasco

    
• • ·Increased numbers of macrophages surrounding hair follicles in patients with cicatricial alopecia

    Page :P92

    Sarolta K. Szabo, Paradi Mirmirani, Faith Durden, Thomas S. McComick

    
• • ·A case of idiopathic leukonychia totalis and partialis

    Page :P93

    Chang Nam Lee, Hyun Jeong Park, Jun Young Lee,, Baik Kee Cho

    
• • ·Results of 60-second timed hair counts in women between the ages of 20–60 years

    Page :P93

    Jeffrey J. Miller, Sharon Fang

    
• • ·Efficacy of a new antidandruff thermophobic foam: arandomised, investigator-blinded trial vs. ketoconazole 2% lotion

    Page :P93

    Massimo Milani, Goffredo Quadri

    
• • ·Alopecia Areata is associated with MICA and an extended HLA haplotype

    Page :P93

    Nazila Barahmani, Mariza de Andrade, Joshua Slusser, Madeleine Duvic

    
• • ·Trichoscan: results using a 5% minoxidil topical solution in men with androgenetic alopecia

    Page :P94

    Rolf Hoffmann

    
• • ·Comparison of three therapeutic shampoos for the treatment of dandruff

    Page :P94

    John W. Toole, Stacey Risk, Mary Beth Finkey, Yohini Appa

    
• • ·Chlorpyrifos as a possible pemphigus-inducing pesticide-an in vitro study

    Page :P94

    Yonit Wohl, Ilan Goldberg, Sarah Brenner

    
• • ·Infliximab in the management of severe pemphigus vulgaris

    Page :P94

    José Pardo, Pedro Mercader, José Sánchez-Carazo, Vicente Oliver

    
• • ·Normal anagen effluvium as the presenting sign of pemphigus vulgaris: a case report

    Page :P95

    Mi-Yeon Kim, You Jeong Kim, Young Min Park,, Hyung Ok Kim

    
• • ·Triethanolamine induced linear IGA dermatosis

    Page :P95

    Molly Smith, Judith Williams

    
• • ·Severe erythema multiforme responding to high dose intravenous immunoglobulin therapy

    Page :P95

    Minal N. Singh, Jason Williams, Tamara Griffiths, Chris Griffiths

    
• • ·Paraneoplastic pemphigus associated with squamous cell carcinoma of the lung

    Page :P95

    Liborka Kos, Henry Wong, Adrian Ormsby

    
• • ·Morbidity and mortality from steroid therapy in pemphigus

    Page :P96

    Carolina F. Gouveia, Vasco Coutinho, Paulo Filipe, J.L. Cirne-de-Castro

    
• • ·IgA mucous membrane pemphigoid in a patient with common variable immunodeficiency

    Page :P96

    Pitiporn Suwattee, David S. Rootman, Danny Ghazarian, P.Regine Mydlarski

    
• • ·Localized linear IgA bullous disease

    Page :P96

    Naveed Sami, Craig Elmets

    
• • ·The a5 and a6 chains of type IV collagen are the target of IgG and IgA autoantibodies in a novel autoimmune disease characterized by crescentic glomerulonephritis and sub-epidermal blisters

    Page :P96

    Reza Ghohestani, Miguel Barria, Guy Webster, Alain Claudy

    
• • ·Tuberculoid leprosy and onchocerciasis in a woman from equatorial guinea

    Page :P97

    José C. Pascual, Rafael Botella, Isabel Belinchón, José Bañuls

    
• • ·Disseminated cutaneous tuberculosis occurring after varicella infection

    Page :P97

    Kathy An, Anthony Wong, Elena Estuita, Edward Heilman

    
• • ·A case of disseminated nocardiosis secondary to the skin nodules in an old woman

    Page :P97

    Gwang Seong Choi, Jung Hyun Shin

    
• • ·Raccoon heartworm causing a leg mass

    Page :P97

    Mandy L Warthan, Molly Warthan, Ronald Hearne, Jack Lesher

    
• • ·Opportunistic mycobacterium fortuitum infection of scalp and nipple-unusual presentations of an unusual pathogen

    Page :P98

    Kim L. Carlson-Sweet, Raashid Haque, Leslie Rainbolt, A.Neil Crowson

    
• • ·Epidemiology of cutaneous tuberculosis in Japan: a retrospective study from 1906 to 2002

    Page :P98

    Manabu Hamada, Kazunori Urabe, Yoichi Moroi, Masutaka Furue

    
• • ·Lucio’ phenomenon: a favorable outcome with multidrug therapy

    Page :P98

    Luna Azulay-Abulafia, Letícia Spinelli, Bernard Kac

    
• • ·Hansen’s disease masquerading as facial keloids

    Page :P98

    Risa J. Gorin, Igor Chaplik, Marcia Deitz, Cindy Hoffman

    
• • ·Tropical bacterial diseases

    Page :P99

    Jashin J Wu, Katie R. Pang, Omar Lupi, Stephen K. Tyring

    
• • ·Effects of two topical antimicrobial agents on staphylococcus aureus biofilms in a porcine model

    Page :P99

    Alex Cazzaniga, Carlos A. Ricotti, Stephen Davis, Patricia Mann Mertz

    
• • ·Lyme borreliosis

    Page :P99

    Katie R. Pang, Jashin J. Wu, Ulrich Hengge, Stephen K. Tyring

    
• • ·Ecthyma gangrenosum

    Page :P99

    Anatoli Freiman, Khue Nguyen, Channy Muhn, Robin Billick

    
• • ·A case of Xeroderma Pigmentosum with Hansen’s disease

    Page :P100

    Kishore D.M. Yellumahanthi

    
• • ·Treatment for toenail onychomycosis: a satisfaction and compliance study

    Page :P100

    Alan W. Sue, Sonja Wustrack, Monika Raut, Amir Tavakkol

    
• • ·Disseminated cryptococcus in AIDS

    Page :P100

    Igor Chaplik, Risa Gorin, Charles Gropper, Richard Hwang

    
• • ·Etiology of tinea capitis in the United States and Puerto Rico, Latin America and Mexico, and India

    Page :P100

    Mahmoud A. Ghannoum, Boni Elewski

    
• • ·A fatal case of trichosporonosis in a renal-transplant patient

    Page :P101

    Jeffery C. Weeks, Sate Hamza, Boni Elewski

    
• • ·Prevalence and epidemiology of onychomycosis in patients visiting physicians’ offices: a multicenter Canadian survey of 35,000 patients

    Page :P101

    Aditya K. Gupta, Aditya Gupta

    
• • ·Pulse vs. continuous terbinafine for treatment of toenail onychomycosis: results of a double-blind controlled trial

    Page :P101

    Erin M. Warshaw, Debra Fett, Joseph Grill, Dave Nelson

    
• • ·Cost analyses of two nail lacquers used for the treatment of onychomycosis infection

    Page :P101

    Line Hamel, Lucie Adjadj

    
• • ·Cost-effective treatment of onychomycosis: a review of the literature

    Page :P102

    Robert Baran, F Baron-Papillon

    
• • ·Pityrosporum folliculitis arising in a renal transplant patient with tinea versicolor

    Page :P102

    Corey L. Hartman, Boni Elewski

    
• • ·Prevention of reinfection in patients successfully treated for toenail onychomycosis: results of a double-blind, randomized, placebo controlled trial

    Page :P102

    Erin M. Warshaw

    
• • ·Sensitivity and cost-effectiveness of diagnostic tests for onychomycosis

    Page :P102

    Erin M. Warshaw, Kia Lilly, Rebecca Koshnick, David Nelson

    
• • ·Cutaneous leishmaniasis: a diagnostic challenge

    Page :P103

    Diana D. Antonovich, Jeffrey P. Callen

    
• • ·Tropical dermatology: fungal tropical diseases

    Page :P103

    Katie R. Pang, Jashin J. Wu, Omar Lupi, Stephen K. Tyring

    
• • ·Cutaneous infection by scedosporium apiospermum and treatment with voriconazole

    Page :P103

    Josep A. Pujol-Montcusi, Pilar Turegano, Francesc Vidal, Cristobal Richart

    
• • ·A randomized, double-blind, double-dummy, placebo-controlled study of the safety and efficacy of ketoconazole foam, 2%, versus ketoconazole 2% cream in the treatment of seborrheic dermatitis

    Page :P103

    Teri Koller, Mary Spellman, Alex Yaroshinsky, Boni Elewski

    
• • ·The treatment of chronic interdigital tinea pedis infection using imiquimod cream 5%

    Page :P104

    Aditya K. Gupta

    
• • ·Ciclopirox nail lacquer in the treatment of onychomycosis

    Page :P104

    Aditya K. Gupta

    
• • ·Evaluation of the mycological cure rates when ciclopirox nail lacquer is used in combination with oral terbinafine to treat toenail onychomycosis-six month interim results

    Page :P104

    Aditya K. Gupta

    
• • ·Management of onychomycosis: combination therapy is not a new concept

    Page :P104

    Aditya K. Gupta

    
• • ·Long-term efficacy rates of terbinafine and itraconazole when used for the management of dermatophyte toe nail onychomycosis

    Page :P105

    Aditya K. Gupta

    
• • ·The diabetic foot

    Page :P105

    Aditya K. Gupta

    
• • ·Ciclopirox gel: an overview

    Page :P105

    Aditya K. Gupta

    
• • ·Ciclopirox shampoo: an overview

    Page :P105

    Aditya K. Gupta

    
• • ·Efficacy and safety of combination therapy with itraconazole and terbinafine to treat dermatophyte toenail onychomycosis

    Page :P106

    Aditya K. Gupta

    
• • ·Assessing the efficacy of the oral antifungal agents in the management of dermatophyte toenail onychomycosis

    Page :P106

    Aditya K. Gupta

    
• • ·Efficacy and safety of intermittent terbinafine therapy to treat dermatophyte toenail onychomycosis

    Page :P106

    Aditya K. Gupta

    
• • ·Molecular identification of Malassezia species by amplified fragment length polymorphism (AFLP) and sequence analyses of the internal transcribed spacer (ITS) and large subunit (LSU) regions of ribosomal DNA

    Page :P106

    Aditya K. Gupta

    
• • ·Role of Malassezia yeasts in seborrheic dermatitis

    Page :P107

    Aditya K. Gupta

    
• • ·Contact immunotherapy with squaric acid dibutylester for the treatment of warts in patients with HIV

    Page :P107

    Jackie M. Tripp, Richard I. Crawford

    
• • ·Prurigo nodularis in an HIV positive patient

    Page :P107

    Annette Loffeld, Chin Tan

    
• • ·Association of penile lichen sclerosus and oncogenic human papillomavirus (HPV) infection

    Page :P107

    Giuseppe Micali, Daniele Innocenzi, Maria Rita Nasca, Aurora Tedeschi

    
• • ·A new and effective delivery system of bleomycin for the treatment of recalcitrant warts

    Page :P108

    Jennifer M. Jones, Raymond Yu, Jean Mooney, Anne Wilson

    
• • ·Granulomatous cutaneous manifestation of cytomegalovirus infection in a patient with AIDS

    Page :P108

    Maira E. Herz, Sergio González, Nora Méndez, Oralia Barboza

    
• • ·Vaccines and immunotherapies for the prevention of infectious diseases having cutaneous manifestations

    Page :P108

    Jashin J. Wu, Katie R. Pang, David B. Huang, Stephen K. Tyring

    
• • ·Presence of HPV DNA sequences in lesional and non-lesional skin warts in twenty patients

    Page :P108

    Alvarez-Ruiz Sara, Dauden Esteban, Alba Alfonso, Garcia-Diez Amaro

    
• • ·Photodistributed eruption as the presenting sign of AIDS

    Page :P109

    Catherine D. Carretero, Henry Lim

    
• • ·Human herpesvirus 8

    Page :P109

    Katie R. Pang, Jashin J. Wu, Stephen K. Tyring

    
• • ·HIV-related opportunistic infections in tropical countries

    Page :P109

    Katie R. Pang, Jashin J. Wu, Stephen K. Tyring

    
• • ·Tropical dermatology: viral tropical diseases

    Page :P109

    Katie R. Pang, Jashin J. Wu, Omar Lupi, Stephen K. Tyring

    
• • ·Epidermodysplasia verruciformis human papillomavirus types are frequently detected in skin lesions associated with HIV infection

    Page :P110

    Jacqueline A. Dyche, Simon Davidson, Ferina Ismail, Judy Breuer

    
• • ·Adjunctive treatment with etanercept in HIV-1-associated tuberculosis

    Page :P110

    Robert S. Wallis, Peter Kyambadde, John Johnson, Libby Horter

    
• • ·Disseminated herpes simplex virus-1 infection in a previously healthy man

    Page :P110

    Angela J. Wyatt, Snehal Amin, Pamela Ng, Dina Began

    
• • ·A review of the uses of imiquimod

    Page :P110

    Aditya K. Gupta

    
• • ·Herpes zoster in a 10 year old child

    Page :P111

    Kishore D.M. Yellumahanthi

    
• • ·Single-blind, randomized, controlled trial to evaluate the efficacy and safety of photodynamic therapy using aminolevulinic acid versusliquid nitrogen cryotherapy in the management of verrucae plantaris

    Page :P111

    Aditya K. Gupta

    
• • ·Unusual cutaneous findings of urticaria pigmentosa and telangiectasia macularis eruptiva perstans associated with marked myelofibrosis

    Page :P111

    Irina Turchin, Benjamin Barankin, Eric Schloss

    
• • ·Vulval Crohn’s disease in a young patient with coexistent ulcerative colitis

    Page :P111

    Christine E. Kleyn, Hazel Bell, Clodagh King

    
• • ·Nephrogenic fibrosing dermopathy following acute renal failure in a patient never treated with dialysis

    Page :P112

    Tamella B. Cassis, Mark Jackson, George Sonnier, Jeffrey Callen

    
• • ·Dyskeratotic dermatitis presenting as squamous cell carcinoma in situ

    Page :P112

    Robert M. Rosen, Peishu Zheng

    
• • ·Pressure-induced bullae and sweat gland necrosis following chemotherapy induction

    Page :P112

    Joshua E. Lane, Chad Brown, Tomasz Marzec, Jack Lesher

    
• • ·Graft-versus-host disease in a liver transplant patient

    Page :P112

    Catherine R. Toms, Amy Theos

    
• • ·Zosteriform metastatic renal cell carcinoma

    Page :P113

    Kimberly A. Davidson, Henry Wong

    
• • ·Cutaneous vasculitis: a retrospective study

    Page :P113

    Asad Dr. Salim, Andrew G. Smith

    
• • ·Metastatic leiomyosarcoma

    Page :P113

    Molly A. Hinshaw, Scott McMartin, Sharata Harry

    
• • ·Cutaneous manifestations of the malignant carcinoid syndrome

    Page :P113

    Christine E. Kleyn, Hazel Bell, Graham Postin, Niall Wilson

    
• • ·Bexarotene gel as adjuvant therapy for mycosis fungoides and lymphomatoid papulosis lesions refractory to oral bexarotene and/or denileukin diftitox

    Page :P114

    Rakhshandra Talpur, Madeleine Duvic

    
• • ·Subcutaneous panniculitis-like T-cell lymphoma

    Page :P114

    João G. Pignatelli, Paulo Filipe, Luı́s Soares de Almeida, João Freitas

    
• • ·A rare variant of cutaneous T-cell lymphoma

    Page :P114

    Helen Radoszycki, Alyson Penstein

    
• • ·Cytokine gene polymorphisms in patch-stage mycosis fungoides

    Page :P114

    E. Hodak, L. Akerman, M. David, B. Kfir, L. Maron, T. Klein

    
• • ·HIV-associated anaplastic CD30+ large-cell lymphoma

    Page :P115

    Lubomira Scherschun, Marsha Chaffins

    
• • ·BCL-2, NFKAPPAB and Caspase-3 expression in lymphomatoid papulosis

    Page :P115

    Bettina M. Prinz, Werner Kempf, Xiaoming Sun, Joan Guitart

    
• • ·T/natural killer-cell lymphomas

    Page :P115

    Karan K. Sra, Renee Synder, Ronald Rapini, Stephen Tyring

    
• • ·Intermediate cell histiocytosis: a case report of a rare disorder

    Page :P115

    Ayad E. Abrou, Ethan Nydorf, Christine Adamick

    
• • ·Follicular mycosis fungoides with anhydrosis

    Page :P116

    David M. Ozog, Holly Kerr, Henry Wong

    
• • ·Constitutional and environmental risk factors for cutaneous melanoma in an italian population. A case-control study

    Page :P116

    Tiziana Manunta, Angela Ferrari, Tamara Micantonio, Ketty Peris

    
• • ·Interobserver concordance of pigmented lesion malignancy risk between a digital dermoscopy system and a pigmented lesion specialist

    Page :P116

    Josephine C. Nguyen, Susan Swetter

    
• • ·Cutaneous amelanotic melanoma metastasis and dermatofibromas dermoscopically characterized by a dotted vascular pattern

    Page :P116

    Maria Manuela Pronestı̀, Federica Formicone, Evelina Giannetti, Ketty Peris

    
• • ·Evaluation of the reproducibility of total dermoscopic score of the Stolz’s ABCD rule as a preoperative predictor of melanoma thickness

    Page :P117

    Patrizia Valeri, Maria Concetta Fargnoli, Gian Piero Lozzi, Ketty Peris

    
• • ·Possible use of flavonoids as cell growth inhibitors in malignant melanoma

    Page :P117

    Ada Girnita, Leonard Girnita, Magnus Axelson, Olle Larsson

    
• • ·Cutaneous miliary pattern in metastasizing thin malignant melanoma

    Page :P117

    Joanna E. Gach, Imtiaz Ahmed, David Snead, Andrew Ilchyshyn

    
• • ·Pattern of first recurrence in melanoma patients after radical lymph node dissection

    Page :P117

    Nir Nathansohn, Jackob Schachter, Haim Gutman

    
• • ·Accuracy of initial biopsy of melanoma and effects on staging, treatment & prognosis

    Page :P118

    Christopher W. Kling, Scott Fosko

    
• • ·A new bidimensional approach for pigmented skin lesions: hypo-epiluminescence microscopy

    Page :P118

    Domenico Piccolo, Claudia Cotellessa, Sergio Chimenti, Ketty Peris

    
• • ·Lupus vulgaris of the face associated with lentigo maligna

    Page :P118

    Zulema Olazarán, Dr.José Eleuterio González, Maira Herz, Dr.José Eleuterio González, Jorge Ocampo, Dr.José Eleuterio González, Oliverio Welsh, Dr.José Eleuterio González

    
• • ·Tanning salon melanoma

    Page :P118

    Thomas F. Downham, Adrian Ormsby

    
• • ·Quantitative analysis of tumor infiltrating lymphocytes in cutaneous melanoma

    Page :P119

    Stefania Motta, Marcello Monti, Barbara Franceschini, Carlo Russo

    
• • ·Congenital melanocytic nevi mimicking metastatic melanoma: congenital eruptive pseudomelanoma

    Page :P119

    Adrian M. Guevara, Mark Naylor, Neil Crowson, Martin Mihm

    
• • ·Quality of life impact by melanoma as measured by utilities

    Page :P119

    Jason C. Hadley, Sandra Bendeck, Katherine Brown, Suephy Chen

    
• • ·Clinical, histological and dermoscopy correlation of pigmentation in excision scars of melanocytic tumors

    Page :P119

    Rafael Botella, Antonio Cremades, Eduardo Nagore, Onofre Sanmartı́n

    
• • ·Malignant melanoma related to longterm use of tanning beds

    Page :P120

    Donna H. Ward, Edward Krull, Thomas Downham

    
• • ·Topical photodynamic therapy with the iron chelator, CP94, for nodular basal cell carcinoma

    Page :P120

    Colin A. Morton, Sandra Campbell, David Gould, Alison Curnow

    
• • ·Atrophic dermatofibrosarcoma protuberans in an adult: an uncommon, misleading variant

    Page :P120

    Mohsin M. Malik, Jason K. Wu, Conleth A. Egan

    
• • ·Successful non-surgical “salvage therapy” of morpheaform basal cell carcinoma in patients refusing surgery

    Page :P120

    Rebecca B. O’Sullivan, Vincent Li

    
• • ·Squamous cell carcinoma of the lip at West Virginia university since 1980

    Page :P121

    Robert Wilson, Jeffrey Jackson

    
• • ·Polypoid skin metastases of renal cell carcinoma

    Page :P121

    Viviana E Garcia, San Cristobal, Sergio Gonzalez

    
• • ·Imiquimod 5% cream for the treatment of cutaneous epithelial neoplasms

    Page :P121

    Ketty Peris, Angela Ferrari, Linda De Angelis, Sergio Chimenti

    
• • ·Long-term clearance of multiple actinic keratoses after topical treatment with imiquimod (5%)

    Page :P121

    Eggert Stockfleth, Bernd Benninghoff, Jan-Ole Busch, Wolfram Sterry

    
• • ·Sunbed related dysplastic keratosis-a report of three cases

    Page :P122

    Ferina F Ismail, S.M Khorshid, E.A O’Toole, J.M McGregor

    
• • ·The effects of topically applied constituents of green tea (caffeine or (−)-epigallocatechin; EGCG) on UV-induced increase in p53 and apoptotic markers in the skin of human volunteers, a pilot study

    Page :P122

    Komal M Pandya, Melissa Magliocco, Rama Malaviya, Melissa Yao

    
• • ·Dermoscopic monitoring of tazarotene treatment of basal cell carcinoma

    Page :P122

    Claudia Cotellessa, Anna Silvia Biamonte, Patrizia Valeri, Ketty Peris

    
• • ·Basal cell carcinoma treated with topical bexarotene 1% gel: an open label controlled study

    Page :P122

    Monika G Kiripolsky, John Zic, Ronald Nelson

    
• • ·Imiquimod 5% cream effective in the treatment of large superficial BCC

    Page :P123

    Stephen Shumack, Kurt Gebauer, Ken Macdonald, Mark Amies

    
• • ·Imiquimid 5% cream dosed 3 times weekly for the treatment of actinic keratosis

    Page :P123

    Neil J. Korman, Mark Ling, Robert Matheson, Stacy Smith

    
• • ·Multiple basal-cell carcinomas associated with a port wine stain

    Page :P123

    Christine D Ambro, Jason Lee, Paul Bujanauskas

    
• • ·Comparison of topical methylaminolevulinate photodynamic therapy versus placebo photodynamic therapy in nodular basal cell carcinoma

    Page :P123

    Whitney D Tope, A Menter, R.A. El-Azhary, N.J. Lowe

    
• • ·Photodynamic therapy using methyl aminolevulinate in patients with basal cell carcinoma

    Page :P124

    Carl Viniciullo, T Elliott, K Gebauer, L Spelman

    
• • ·A Phase IV, Open-label assessment of the treatment of actinic keratoses with diclofenac sodium 3% topical gel

    Page :P124

    Darrell S Rigel, Neal Swanson, John Wolf, Stacy Smith

    
• • ·Efficacy by clinical evaluation of imiquimod 5% cream in the treatment of superficial basal cell carcinoma: initial results from an ongoing, long-term follow-up study in Europe

    Page :P124

    Harald Gollnick, Carlos Guillen Barona, Ronald Frank, Thomas Ruzicka

    
• • ·Efficacy by clinical evaluation of imiquimod 5% cream in the treatment of superficial basal cell carcinoma: initial results from an ongoing, long-term follow-up study in Australia and New Zealand

    Page :P124

    Kurt Gebauer, Chris Quirk, Brian De’Ambrosis, Mark Amies

    
• • ·Successful treatment of vulvar bowen’s disease with topical imiquimod 5% cream

    Page :P125

    Bo Kyung Koh, Yeon Jeong Kim, Kyung Ho Lee, Jin Woo Kim

    
• • ·Detection and clearance of subclinical actinic keratosis (AK) with imiquimod (5%) treatment

    Page :P125

    Eggert Stockfleth, Jens Bichel, Claas Ulrich, Wolfram Sterry

    
• • ·A case of cutaneous metastasis from hepatic leiomyosarcoma

    Page :P125

    Jeong-Soo Kim, Hee-Joon Yu, Kwang-Yeoll Yeo

    
• • ·Morphologic characteristics of skin cancer as studied through echography

    Page :P125

    Jose M. Fernandez-Vozmediano, Jose Armario-Hita

    
• • ·A patient with xeroderma pigmentosum treated with imiqimod 5% cream

    Page :P126

    Kim Lapiere, Tamar Nijsten, Sarah Caers, Julien Lambert

    
• • ·Basal cell carcinoma of the nipple and areola: a case report and review of the literature

    Page :P126

    Nathan Rosen, Channy Muhn, Steven Bernstein

    
• • ·Different dosing regimens of imiquimod 5% cream can be used to safely and effectively treat actinic keratosis

    Page :P126

    Joseph Jorizzo, Mark Lebwohl, Stuart Salasche, Eggert Stockfleth

    
• • ·Imiquimod 5% cream induces cell-mediated immune response

    Page :P126

    Mary Owens, Ross Barnetson, Gary Halliday, Andrew Satchell

    
• • ·Acitretin suppression of squamous cell carcinoma

    Page :P127

    Daniel A. Carrasco, Mark Lebwohl, C Tannis

    
• • ·Efficacy of imiquimod 5% cream in the treatment of superficial basal cell carcinoma

    Page :P127

    John Geisse, Ivor Caro, Jane Lindholm, Loren Golitz

    
• • ·Loss of 14-3-3s expression in basal cell carcinoma by epigenetic silencing via CpG-methylation

    Page :P127

    Thomas Herzinger, Dimitri Lodygin, Amir S. Yazdi, Heiko Hermeking

    
• • ·Disseminated merkel cell carcinoma in HIV

    Page :P127

    David F Horne, Pamela Ng, Diane Berson

    
• • ·Cutaneous metastasis to the chest wall from prostate cancer

    Page :P128

    Jashin J Wu, Katie R. Pang, David B. Huang, Stephen K. Tyring

    
• • ·A scoring system for actinic keratoses

    Page :P128

    Stephen Slater, Mark Goodfield

    
• • ·Recalcitrant plantar wart or squamous cell carcinoma?

    Page :P128

    Brigitte A. Holder, Jayashree Ravishankar, Yelva Lynfield

    
• • ·One-week treatment with topical 0.5% fluorouracil followed by adjunctive cryosurgery in treatment of actinic keratoses: six month follow-up

    Page :P128

    Joseph Jorizzo, Jonathan Weiss, Katharine Furst, Christine Vandepol

    
• • ·Successful treatment with topical 0.5% fluorouracil and imiquimod 5% cream in the treatment of a patient with actinic keratosis and squamous cell carcinoma

    Page :P129

    Helen M Torok

    
• • ·Basal cell carcinoma metastatic to the bone

    Page :P129

    Molly M Warthan, Mandy Warthan, Ronald Hearne, Jack Lesher

    
• • ·IMTD: an algorithm-based approach to optimize dose-response in treatment of skin cancer using imiquimod

    Page :P129

    Sarvenaz Zand, William W. Li, Vincent W. Li

    
• • ·Single-blind, randomized controlled trial to evaluate the efficacy and safety of photodynamic therapy using aminolevulinic acid versus 5-fluorouracil in the management of actinic keratosis

    Page :P129

    Aditya K Gupta

    
• • ·Oculotrichodysplasia(OTD)

    Page :P130

    Khalid A Al Aboud, Khalid Al Hawsawi

    
• • ·Topical vitamin E solution versus placebo in the treatment of yellow nail syndrome: a randomized double-blind study

    Page :P130

    Emily M Lambert, Richard Antaya

    
• • ·Chilblain lupus in a child

    Page :P130

    José Suarez, Férnández de Misa Ricardo, Perera Antonio, Feliciano Laura

    
• • ·A series of clinically atypical naevi in children

    Page :P130

    Rebecca J Batchelor, Dr Sheila M Clark

    
• • ·The diaper rash that needed more than a little cream

    Page :P131

    Victoria R Barrio, Jeffrey Callen

    
• • ·Childhood pemphigus foliaceus with conjunctivitis

    Page :P131

    Timothy H Clayton, Alison Layton, Shelia Clark, Fenella Wojnarowska

    
• • ·Tuberculous abscess in a 2-year-old resembling clinically and radiologically a lymphatic malformation

    Page :P131

    Simone Laube, Jane Clarke, Dakshish Parikh, Celia Moss

    
• • ·Evolving lesions of phakomatosis pigmentokeratotica

    Page :P131

    Salim Asad, Celia Moss

    
• • ·Topical tacrolimus is a safe and effective treatment for inverse psoriasis in children

    Page :P132

    Jennifer A. Steele, Christine Choi, Pearl Kwong

    
• • ·Generalised papular umbilicated granuloma annulare in a child

    Page :P132

    Rebecca J Batchelor, Dr Sheila Clark

    
• • ·Pyoderma gangrenosum involving labia minora

    Page :P132

    Pitiporn Suwattee, Elena Pope

    
• • ·Case report and review of congenital biotinidase deficiency

    Page :P132

    Mark H Fleischman, Raymond Cornelison, James Coldwell

    
• • ·Cutaneous ossification in an infant

    Page :P133

    Divya Railan, Bryan Zweig, Patricia Treadwell

    
• • ·Neurofibromatosis type 1, mastocytoma and autism

    Page :P133

    Catharine M Walsh, Pitiporn Suwattee, Elena Pope

    
• • ·Response of ulcerated perineal hemangiomas to becaplermin gel

    Page :P133

    Brandie J Metz, Denise Metry, Moise Levy

    
• • ·Hypopigmented mycosis fungoides in children

    Page :P133

    Allison G Zysman, Dina N. Anderson, Sharon A. Glick, Yelva Lynfield

    
• • ·Palmoplantar eccrine hidradenitis induced by subacute cold injury: the same entity as childhood pernio?

    Page :P134

    Paula D Zook, Robin Hornung, Zsolt Argenyi

    
• • ·Molluscum contagiosum in children-who gets them?

    Page :P134

    Lawrence F Eichenfield, Magdalene Dohil, Amy Paller, Ann Lucky

    
• • ·Surprising case of generalized alopecia in an infant

    Page :P134

    Hakim D Miriam, Natalie Nasser, Brenda Moroz

    
• • ·Chronic actinic dermatitis successfully treated with mycophenolate mofetil

    Page :P134

    Michelle Thomson, Graeme Stewart, Helen Lewis

    
• • ·A case of xeroderma pigmentosum (XPA) with no skin cancers

    Page :P135

    Nabla M Mc Loone, Shane McKee, Kevin McKenna

    
• • ·In vitro and in vivo assessment of UVA protection of sunscreens with traditional actives zno and avobenzone and new UV absorbers MBBT and BEMT

    Page :P135

    Uli Osterwalder, Sebastien Mongiat, Bernd Herzog

    
• • ·Sun protection beyond sunburn-UV-protection in non-caucasians

    Page :P135

    Werner Baschong, Carl Artman, Monika Schaumann, Uli Osterwalder

    
• • ·Dual porphyria: a case of acute intermittent porphyria in association with porphyria cutanea tarda, and a four year follow up

    Page :P136

    Jason D.L. Williams, Russell Ead, Brian Kirby, Felicity Stewart

    
• • ·Oral polypodium leucotomos extract protects against ultraviolet induced damage to human skin

    Page :P136

    Maritza A Middelkamp-Hup, Madhu Pathak, Thomas Fitzpatrick, Salvador Gonzalez

    
• • ·Changes of skin surface temperature influence UV-induced acute human skin reaction in vivo

    Page :P136

    Oh Sang Kwon, Eun Ju Hwang, Seong Jin Jo, Jin Ho Chung

    
• • ·Photodynamic therapy-induced pain: a patient centred survey

    Page :P136

    Natasha Kapur, Kristin Kernland Lang, Lasse Braathen

    
• • ·A re-assessment of the procedures for predecting the photosensitization potential of topical products

    Page :P137

    Monya L Sigler, Thomas Stephens, Ronald Rizer, Otto Mills

    
• • ·Costing narrow-band UVB phototherapy in psoriasis

    Page :P137

    Sinead M Langan, Adrienne Heerey, Michael Barry, Louise Barnes

    
• • ·Eicosanoid receptors showed down-regulation after UVA irradiation of atopic dermatitis lesional keratinocytes

    Page :P137

    Peter Arenberger, Iva Obstova, Daniela Blahova, Lenka Paralova

    
• • ·Immediate and long term skin benefits of an after sun treatment containing non-denatured total soy extract

    Page :P137

    Theresa Chen, Claude Saliou, Ronald Rizer, Yohini Appa

    
• • ·Alpha lipoic acid is ineffective as a topical photoprotectant of skin

    Page :P138

    Pinnell R Sheldon, J.Y. Lin, Fu-Hsiung Lin, James A. Burch

    
• • ·A new superficial peeling for the treatment of melasma

    Page :P138

    Otavio R Macedo, Adriana Salgado

    
• • ·An open-label study of the safety and efficacy of triple-combination therapy of melasma in african-american patients

    Page :P138

    Pearl E Grimes

    
• • ·Connection of tacrolimus and 308nm excimer laser in treating vitiligo

    Page :P138

    Thierry Passeron, Nima Ostovari, Wassim Zakaria, Jean-Paul Ortonne

    
• • ·A combined solution of 2% 4-hydroxyanisole and 0.01% tretinoin in the treatment of solar lentigenes: a clinical study on efficacy and safety

    Page :P139

    Harry Katz, H.K. Luber, A Ison, J Hickman

    
• • ·An 8 month efficacy and safety evaluation of a triple combination agent in the treatment of melasma

    Page :P139

    Helen Torok, I Wills, N Brody, J Wieder

    
• • ·A triple combination agent in the treatment of melasma

    Page :P139

    Terry Jones, P Rich, S.R. Smith, HM Torok

    
• • ·GENERALIZED VITILIGO WITH THE POSSIBILITY OF MISDIAGNOSIS AS PIGMENTARY DISEASES: CASE REPORT

    Page :P139

    Sang Ju Lee, Young Koo Kim, Seung-Kyung Hann

    
• • ·Comparison clinical study of the efficacy and safty of fluocinolone acetonide, hydroquinone and tretinoine vs hydroquinone and tretinoine for melasma treatment

    Page :P140

    Ortiz Y, Leon G, R.E. Benuto, H Muñoz, I Arellano, M.E. Arrocha, L Boeta, G Luna, M.L. Morales

    
• • ·Minocycline-induced hyperpigmentation resolves during oral isotretinoin therapy

    Page :P140

    Eric Z Berkowitz, Steven Cohen

    
• • ·An overview of melasma therapies

    Page :P140

    Aditya K Gupta

    
• • ·Repigmentation does not affect tolerance to NB-UVB light in patients with vitiligo

    Page :P140

    Iltefat H Hamzavi, Kim Yue, Stephanie Deleon, George Murakawa

    
• • ·Continuance on etanercept after early incomplete response in patients with psoriasis

    Page :P141

    Gerald G Krueger, Mark Lebwohl, Andrea Wang, Ralph Zitnik

    
• • ·A multi-center study of calcipotriene 0.005% ointment and clobetasol proprionate 0.05% foam in the sequential treatment of localized plaque-type psoriasis

    Page :P141

    Robin R Blum, Dana Stern, John Koo, Mark Lebwohl

    
• • ·A 12-week open-label followed by 4-week double-blind study to determine the safety and efficacy of an extended course of alefacept (LFA-3/igg1 fusion protein) in subjects with chronic plaque psoriasis

    Page :P141

    Carin H. Gribetz, Robin Blum, Steven Cohen, Mark Lebwohl

    
• • ·Infliximab in the management of severe and refractory psoriasis

    Page :P141

    Laura Mahiques-Santos, Teresa Martinez-Menchon, Jose Luis Sanchez-Carazo, Vicente Oliver-Martinez

    
• • ·Global safety and efficacy of more than 5 years of etanercept therapy in rheumatoid arthritis

    Page :P142

    Mark Lebwohl, Alice Gottlieb, Wayne Wallis, Ralph Zitnik

    
• • ·A comparison of biologic therapies for psoriasis

    Page :P142

    William Abramovits, Lisa C. Stevenson

    
• • ·A comparison of the hepatotoxicity caused by different schedules of methotrexate administration

    Page :P142

    Shahdad E Behnam, Mark Eliason

    
• • ·Calcitriol 3μG/G ointment in the treatment of chronic plaque psoriasis

    Page :P142

    Lisa Schwartz, A Menter, J Weiss, S.D. Clark

    
• • ·Assessment of the efficacy and safety of calcitriol 3μG/G ointment in the treatment of chronic plaque psoriasis

    Page :P143

    Lisa Schwartz, J Powers, J Balin, S Kempers

    
• • ·A new anti-psoriatic ointment yields high efficacy irrespective of initial disease levels

    Page :P143

    Norman R Wasel

    
• • ·Consistent responses from 4 weeks topical treatment of psoriasis with a two-compound product (calcipotriene/betamethasone diproprionate),

    Page :P143

    Scott J Murray

    
• • ·Successful treatment of recalcitrant palmoplantar psoriasis with etanercept

    Page :P143

    Jeffrey M Weinberg

    
• • ·Efficacy of once daily application of a new two-compound calcipotriene/betamethasone dipropionate ointment in extensive psoriasis

    Page :P144

    Knud Kragballe, Preben Olsen

    
• • ·A highly effective once daily treatment with a new two-compound calcipotriene/betamethasone dipropionate ointment in psoriasis vulgaris

    Page :P144

    Knud Kragballe, Kirsten Noerrelund

    
• • ·Consistency in data in the first six studies on a new two-compound product (calcipotriene and betamethasone dipropionate) in psoriasis patients

    Page :P144

    Jette Traulsen

    
• • ·Costs of managing severe psoriasis across seven European countries

    Page :P144

    Aldo F Finzi, Adam Lloyd, David Scott, Amitabh Singh

    
• • ·Improvement in nail psoriasis with alefacept

    Page :P145

    Jenny Sobera, Charles Parrish, Boni Elewski

    
• • ·Safety of cyclosporine in patients with psoriasis

    Page :P145

    José María Hernanz, Lluis Puig, Estebán Daudén

    
• • ·Improvement of severe psoriatic nail involvement with alefacept therapy

    Page :P145

    Jeffrey P Callen

    
• • ·Sustained improvement in activities of daily living and vitality in patients with psoriatic arthritis treated with etanercept

    Page :P145

    Lee A. Wanke, Philip Mease, Alice Gottlieb, Daniel Burge

    
• • ·Withdrawal from etanercept after successful clinical response in psoriasis patients: disease characteristics and the durability of treatment response

    Page :P146

    Alice B Gottlieb, Kenneth Gordon, Andrea Wang, Ralph Zitnik

    
• • ·The efficacy and safety of etanercept in the re-treatment of psoriasis after relapse

    Page :P146

    Craig L Leonardi, Boni Elewski, Charles Camisa, Ralph Zitnik

    
• • ·Mechanisms of disease: angiogenesis, vascular endothelial growth factor (VEGF) and psoriasis

    Page :P146

    Helen S Young, Angela Summers, Paul Brenchley, Christopher Griffiths

    
• • ·Successful treatment of psoriasis and psoriatic arthritis with etanercept and methotrexate in a patient newly unresponsive to infliximab

    Page :P147

    Bruce E Strober

    
• • ·Efficacy of etanercept in psoriatic patients previously treated with systemic therapy or phototherapy

    Page :P147

    Bruce E Strober, Paul Yamauchi, Neil Korman, Seth Stevens

    
• • ·Comparative pharmacokinetics of etanercept in patients with psoriasis or rheumatoid arthritis

    Page :P147

    Ivan Nestorov, Todd DeVries, Ralph Zitnik

    
• • ·Pharmacokinetic profile of oral tazarotene

    Page :P147

    Dale Yu, Jinsong Ni, Mayssa Attar, Diane Tang-Liu

    
• • ·Pharmacokinetics of etanercept, a TNF antagonist, in patients with psoriasis treated in two double-blind phase 3 trials

    Page :P148

    Ivan Nestorov, Todd DeVries, Ralph Zitnik

    
• • ·Pharmacokinetics of etanercept in patients with psoriasis are similar after either intermittent or continuous treatment

    Page :P148

    Ivan Nestorov, Todd DeVries, Ralph Zitnik

    
• • ·Pharmacology of oral tazarotene

    Page :P148

    Jayasree Vasudevan, Roshantha Chandraratna

    
• • ·Rational design of tazarotene

    Page :P148

    Jayasree Vasudevan, Roshantha Chandraratna

    
• • ·Quality of life effect of oral tazarotene in patients with moderate to severe psoriasis as measured by the 12-item psoriasis quality of life questionnaire (PQOL-12)

    Page :P149

    John Y.M. Koo, Jonathan Kowalski, Lyn Guenther, Patricia Walker

    
• • ·Topical tacrolimus ointment in combination with 6% salicylic acid gel for treatment of psoriasis: results of a randomized, double blind, right to left clinical trial

    Page :P149

    Christie L Carroll, Jan Clarke, Rajesh Balkrishnan, Steven Feldman

    
• • ·Trends in electronically monitored adherence to topical therapy

    Page :P149

    Christie L Carroll, Fabian Camacho, Steven Feldman, Rajesh Balkrishnan

    
• • ·Non-laser targeted UV treatment for localized psoriasis

    Page :P149

    Judy Hu, Mandeep Kaur, Steven Feldman

    
• • ·Psoriasis & quality of life: spot study, results at 3 months

    Page :P150

    Eric Myon, Andrew Finlay, Charles Taı̈eb

    
• • ·Retrospective study of the use of acitretin: frequent use in combination with other treatments

    Page :P150

    Judy Hu, Rajesh Balkrishnan, Wei Lang, Alan Fleischer

    
• • ·Study of patient preferences for ointment, cream and foam formulations

    Page :P150

    Ann McCarty, Steven Feldman

    
• • ·Use of superpotent topical corticosteroids for psoriasis patients in the U.S.

    Page :P150

    Dan Pearce, Alan Fleischer, Rajesh Balkrishnan, Steven Feldman

    
• • ·Class I topical corticosteroid use for psoriasis patients in an academic practice

    Page :P151

    Dan Pearce, Alan Fleischer, Steven Feldman

    
• • ·Alefacept in combination with tapering doses of methotrexate in patients with psoriasis

    Page :P151

    Alan Menter, William Abramovits, Jennifer Cather

    
• • ·Long-term use of intravenous alefacept: safety and off-treatment responses in patients who have received four or more courses of therapy

    Page :P151

    Alan Menter, Jennifer Cather

    
• • ·Alefacept in the treatment of psoriatic nail disease

    Page :P151

    Bruce E Strober, Chris Cassetty

    
• • ·Efficacy of multiple courses of alefacept in combination with other psoriasis therapies: a study that reflects the clinical practice setting

    Page :P152

    Kenneth Gordon, Wolfram Sterry

    
• • ·Safety of multiple courses of alefacept in combination with other psoriasis therapies: a study that reflects the clinical practice setting

    Page :P152

    Gerald Krueger, Peter van de Kerkhof

    
• • ·The safety of alefacept using a reduced schedule for monitoring T cells

    Page :P152

    Richard Langley, Diane Baker, Janet Roberts

    
• • ·Pilot trial of topical bexarotene gel in mild to moderate plaque psoriasis

    Page :P152

    Debra L Breneman, Pranav Sheth, Victor Stevens

    
• • ·Evaluating psoriasis severity: limitations of the PASI and advantages of the overall lesional assessment

    Page :P153

    Deborah Lew-Kaya, John Lue, John Sefton, Patricia Walker

    
• • ·Safety of oral tazarotene in moderate to severe plaque psoriasis

    Page :P153

    Patricia S. Walker, Alice Gottlieb, Lyn Guenther, Alan Menter

    
• • ·An open-label extension study evaluating the efficacy and safety of oral tazarotene in plaque psoriasis

    Page :P153

    Kim A Papp, Frederick Beddingfield, Susan Manrow, Patricia S. Walker

    
• • ·Oral tazarotene and difficult-to-treat psoriatic lesions

    Page :P153

    Sewon Kang, Alan Menter, Patricia S. Walker

    
• • ·Duration of clinical improvement with oral tazarotene in plaque psoriasis

    Page :P154

    John Y.M. Koo, Nicholas Lowe, John Sefton, Patricia S. Walker

    
• • ·Oral retinoids in the treatment of psoriasis

    Page :P154

    Madeleine Duvic, Sewon Kang, Jerry Tan, John Sefton

    
• • ·Safety of large area application of a novel vitamin D analogue (Tisocalcitate ointment) in healthy volunteers

    Page :P154

    Torsten Zimmermann, Thomas Staks, Angelika Jahreis, Eugene O’Keefe

    
• • ·Psoriasis treatment in the U.S. at the end of the 20th century

    Page :P154

    Daniel J Pearce, Alan Fleischer, Steven Feldman, Rajesh Balkrishnan

    
• • ·Clinically meaningful improvements in health-related quality of life from etanercept therapy for patients with moderate to severe psoriasis

    Page :P155

    Steven R Feldman, Alexa Kimball, J.Michael Woolley, Ralph Zitnik

    
• • ·The effects of etanercept therapy on patient reported outcomes for patients with moderate to severe psoriasis

    Page :P155

    Gerald G. Krueger, J.Michael Woolley, Ralph Zitnik

    
• • ·Etanercept reduces pruritus in patients with moderate to severe psoriasis

    Page :P155

    Alexa B. Kimball, J.Michael Woolley, Ralph Zitnik

    
• • ·The value of persistent treatment of psoriasis with etanercept

    Page :P155

    Richard G.B. Langley, J.Michael Woolley, Seth Stevens

    
• • ·The dermatology life quality index (DLQI) provides qualitatively different information from the pasi

    Page :P156

    Alexa B. Kimball, Gerald Krueger, J.Michael Woolley

    
• • ·Oral tazarotene improves scalp psoriasis

    Page :P156

    Emil A Tanghetti, Yves Poulin, Patricia S. Walker

    
• • ·Impact of efalizumab on patient-reported outcomes in patients with moderate to severe plaque psoriasis: pooled results from three randomized phase III trials

    Page :P156

    Alan Menter, Tiffani Hamilton, Ivor Caro, Amy Chen-Rundle

    
• • ·Safety of efalizumab in patients with psoriatic arthritis: results of a phase II, randomized, double-blind, placebo-controlled study

    Page :P156

    Kim Papp, Phil Mease, Marvin Garovoy, David Zhang

    
• • ·Interpretation of positive patient response to efalizumab for the treatment of moderate to severe plaque psoriasis

    Page :P157

    Stephen Stone, Kim Papp, Ivor Caro, Brian Bresnahan

    
• • ·Long-term efalizumab therapy safely maintains psoriasis area and severity index improvement: preliminary results from an open-label trial

    Page :P157

    Alice Gottlieb, Kenneth Gordon, Ivor Caro, Craig Leonardi

    
• • ·Infliximab improves signs of plaque psoriasis in patients with psoriatic arthritis

    Page :P157

    Alice B Gottlieb, Robert Evans, Kamlesh Patel, Robert Matheson

    
• • ·The safety of efalizumab in patients with moderate to severe plaque psoriasis: summary of clinical trial experience

    Page :P157

    Craig Leonardi, Bernard Goffe, Jeff Sobell, Ivor Caro

    
• • ·The efficacy of infliximab in specific areas of the body

    Page :P158

    Alice B Gottlieb, Robert Evans, Robert Matheson, Bruce Miller

    
• • ·The efficacy of infliximab across a variety of subgroups with plaque psoriasis

    Page :P158

    Alice B Gottlieb, Robert Evans, Shu Li, Craig Leonardi

    
• • ·Safety of etanercept in an integrated multi-study database of patients with psoriasis

    Page :P158

    Alice B. Gottlieb, Bernard Goffe, Joachim Veith, Seth Stevens

    
• • ·Pharmacokinetics of infliximab in patients with severe plaque psoriasis

    Page :P158

    Yaowei Zhu, Martin Graham, Alan Menter, Alice B. Gottlieb

    
• • ·Efficacy and safety of etanercept in patients with psoriasis: results of a global phase iii study

    Page :P159

    Boni E. Elewski, Erin Boh, Kim Papp, Ralph Zitnik

    
• • ·A literature review of the use of infliximab in dermatological diseases

    Page :P159

    Aditya K Gupta

    
• • ·Lymphangiomas: a 10 years review

    Page :P159

    Teresa Martı́nez-Menchón, Laura Mahiques Santos, Isabel Febrer-Bosch, José Miguel Fortea Baixauli

    
• • ·Moisturizer efficacy: a kinetic approach

    Page :P159

    Ronald L Rizer, Karl Beutner, Otto Mills

    
• • ·Skin conditioning benefits of cleansers

    Page :P160

    Ronald L. Rizer, Karl Beutner, Otto Mills

    
• • ·Evaluation of topically applied agents on compromised skin

    Page :P160

    Ronald L. Rizer, Karl Beutner, Otto Mills

    
• • ·Treatment of lower eyelid fat pads using phosphatidylcholine

    Page :P160

    Adam M. Rotunda

    
• • ·A bilateral comparison of the efficacy and safety of photodynamic therapy with 20% aminolevulinic acid (ALA) topical solution and intense pulsed light versus intense pulsed light alone in the treatment of mild to moderate photoaging

    Page :P160

    Jeffrey S. Dover, Ashish Bhatia, Brigette Stewart, Kenneth Arndt

    
• • ·Instrumental evaluation of a model of purpura induced by pulsed dye laser.

    Page :P161

    David R. Black, Jennifer Theunis, Serge Dahan, Jean Luc Levy

    
• • ·Antibiotic prophylaxis revisited

    Page :P161

    Tina Suneja, Paul H. Bowman

    
• • ·Mohs micrographic surgery for angiolymphoid hyperplasia with eosinophilia

    Page :P161

    Christopher J. Miller, Christie Ammirati, Michael Ioffreda

    
• • ·Radiofrequency surgery-a safe, effective technique for sensitive areas of body

    Page :P161

    Bipin B. Deshpande

    
• • ·Pyogenic granuloma developing in response to exposed sternotomy wire

    Page :P162

    Marian E. Northington, Conway Huang

    
• • ·No smoking gun: findings from a national survey of office-based cosmetic surgery adverse event reporting

    Page :P162

    Rajesh Balkrishnan, Inderjit Gill, Jeffrey Vallee, Steven Feldman

    
• • ·Safety, efficacy and costs of office-based surgery: key findings of the center for dermatology research

    Page :P162

    Phillip M. Williford, John Chen, Rajesh Balkrishnan, Alan Fleischer

    
• • ·Avoiding nerve injury in the head and neck during mohs surgery

    Page :P162

    Thi T. Tran, Matt Muellenhoff, Keoni Nguyen, Steven Proper

    
• • ·Ultrasound imaging demonstration of the improvement of non ablative laser remodelling by concomitant daily topical application of 0.05% retinaldehyde

    Page :P163

    Serge R. Mordon, Jean Michel Lagarde, Serge Dahan

    
• • ·Pulsed light for the treatment of keloidal and hypertrophic scars

    Page :P163

    Kanokwan Chantauppalee, Suthep Jerasutus

    
• • ·Laser hair removal: comparison of long-pulsed Dd:YAG, long-pulsed alexandrite, and long-pulsed diode lasers

    Page :P163

    Navid Bouzari, Hossein Tabatabai, Alireza Firooz, Yahya Dowlati

    
• • ·The role of number of treatments in laser-assisted hair removal using a 755 nm alexandrite laser

    Page :P163

    Hossein Tabatabai, Navid Bouzari, Alireza Firooz, Yahya Dowlati

    
• • ·A single center, open label investigator study of photodynamic therapy in the treatment of sebaceous gland hyperplasia with topical 20% 5-aminolevulinic acid with visible blue light or intense pulsed light

    Page :P164

    Michael H. Gold

    
• • ·Pulse dye laser therapy is an effective treatment for telangiectases associated with scleroderma

    Page :P164

    Virginia G. Hubbard, Sean Whittaker, Malcolm Rustin, Will Clayton

    
• • ·Local molluscum contagiosum infection as a side effect of pulsed dye laser treatment

    Page :P164

    Roland M. Strauss, Robert A. Sheehan-Dare

    
• • ·A single center, open label split face investigator study of photodynamic therapy in the treatment of photoaging with topical 20% 5-aminolevulinic acid and intense pulsed light

    Page :P164

    Michael H. Gold

    
• • ·A new high intensity uv light source for the treatment of stretch marks

    Page :P165

    Michael H. Gold

    
• • ·Non-invasive, non-ablative treatment for the reduction in the appearance of wrinkles using high-frequency electricity combined with vacuum

    Page :P165

    Michael H. Gold

    
• • ·Treatment of superficial benign vascular and pigmented lesions with a combination of pulsed light and radiofrequency energy

    Page :P165

    Suleman Bangash

    
• • ·Does magnetic resonance scanning of port wine stains predict response to pulsed-dye laser treatment?

    Page :P165

    Helen S. Young, Janice Ferguson, Charles Hutchinson, Paul August

    
• • ·Dissecting cellulitis treated with Nd:YAG laser

    Page :P166

    Brett D. Krasner, Iltefat Hamzavi, Fasahat Hamzavi

    
• • ·Wound healing and cortiosteroids: from gene chips to footprints

    Page :P166

    Olivera Stojadinovic, Marjana Tomic, Brian Lee, Harold Brem

    
• • ·Tacrolimus 0.1% ointment for peristomal skin disease

    Page :P166

    M.Shane Chapman, Joanne Brown, Wendy Manganiello

    
• • ·In vivo evaluation of the bactericidal activity of three wound antiseptics on biofilms of common wound pathogens

    Page :P166

    Anna Droussou, Alex Cazzaniga, Stephen Davis, Patricia Mann Mertz

    
• • ·Massive scalp ulceration due to giant cell arteritis and osteomyelitis: successful tissue repair and wound healing using human fibroblast-derived dermal substitute

    Page :P167

    Diego E. Marra, Sarvenaz Zand, William W. Li, Vincent W. Li

    
• • ·Effect of short-contact topical tretinoin therapy on lower extremity ulcers in diabetic patients

    Page :P167

    David H. Peng, Tissa Hata, Tom Wynnis

    
• • ·In vitro evaluation of biofilm development on tissue engineered skin

    Page :P167

    Carlos A. Charles, Carlos Ricotti, Stephen Davis, Robert Kirsner

    
• • ·Pulse oximetry: a simpler method of arterial assessment in venous dermatitis and leg ulcer

    Page :P168

    Mozheh Zamiri, Janice Bianchi, Robert Dawe, Stewart Douglas

    
• • ·Analysis of fibroblast defects in extracellular matrix production in chronic wounds

    Page :P168

    Yvonne Foy, Jie Li, Robert Kirsner, William Eaglstein

    
• • ·Silver dressings: effective antimicrobial therapies?

    Page :P168

    Stephen C. Davis, Alex Cazzaniga, Carlos A. Ricotti, Patricia Mertz

    
• • ·3 layer tubular pressure/support bandages is an alternative and effective form of compression in the management of venous leg ulceration

    Page :P169

    Girish K. Patel, Miar Llewellyn, John Mellhuish, Keith Harding

    
• • ·Evaluation of the effects of a zinc/iron solution on the migration of fibroblasts in an in-vitro incisional wound healing model

    Page :P169

    Alyssa Feiner, Alex Cazzaniga, Stephen Davis, Patricia Mann Mertz

    
• • ·Dramatic improvement of wound closure in nonhealing chronic leg ulcers after topical application of an antitumor necrosis factor-alpha monoclonal antibody (infliximab)

    Page :P169

    Markus Streit

    
• • ·An open-label study of the use of adapalene cream and a triple-combination therapy for the treatment of mild-to-moderate acne and post-inflammatory hyperpigmentation

    Page :P169

    Valerie D. Callender

    
• • ·Counseling to optimize compliance in adolescent acne patients treated with topical retinoids

    Page :P170

    James L. Campbell

    
• • ·Examining the available evidence of topical retinoid use in acne vulgaris: does initial exacerbation of acne commonly precede improvement and is it necessary to induce irritation in order to achieve clinical benefit?

    Page :P170

    James Q. Del Rosso

    
• • ·Using adapalene and non-ablative laser resurfacing to maintain cosmetic benefits

    Page :P170

    Michael H. Gold

    
• • ·Combination phototherapy and adapalene in the treatment of acne vulgaris

    Page :P170

    Mark Steven Nestor

    
• • ·The use of oral tetracyclines for the treatment of common inflammatory facial dermatoses: perspectives on antibiotic vs anti-inflammatory dosing regimens

    Page :P171

    James Q. Del Rosso, Joseph Bikowski

    
• • ·The clinical value of benzoyl peroxide cleanser: formulation characteristics, method of use, drug deposition and clinical efficacy

    Page :P171

    James Q. Del Rosso

    
• • ·An open label, randomized crossover patient preference comparison of doxycycline tablets and doxycycline capsules for the treatment of acne vulgaris

    Page :P171

    Stacy R Smith, Daniel Piacquadio

    
• • ·Skin permeation profile of clindamycin in foam and gel formulations

    Page :P171

    H. Tanojo, J. Lenn, X. Huang

    
• • ·Results of procedural and prescription therapy for medical and cosmetic conditions in dermatology

    Page :P172

    Mark Steven Nestor

    
• • ·Synergism between cryotherapy and application of depigmenting topical solution in the treatment of solar lentigines

    Page :P172

    Dow Stough, Tim Dugan

    
• • ·Treatment of seborrheic dermatitis: focus on the use of pimecrolimus

    Page :P172

    James Q. Del Rosso

    
• • ·A current appraisal of drug interactions of significance in clinical practice: focus on antifungal therapeutic agents used in the treatment of superficial mycoses

    Page :P172

    James Q. Del Rosso

    
• • ·The reemergence of sulfacetamide-sulfur formulations in the treatment of common inflammatory facial dermatoses: focus on the role of cleansers as adjunctive therapy in the treatment of rosacea

    Page :P173

    James Q. Del Rosso

    
• • ·The use of foam vehicle topical corticosteroid formulations in combination with other topical agents: a clinical perspective based on available studies and observational use

    Page :P173

    James Q. Del Rosso

    
• • ·Evaluating physician & patient perspectives regarding managment of seborrheic dermatitis: focus on antifungal shampoo therapy with ciclopirox

    Page :P173

    James Q. Del Rosso

    
• • ·Compatibility of betamethasone 17-valerate and ketoconazole foam formulations in combination topical therapy

    Page :P173

    H. Tanojo, J. Lenn, X. Huang

    
• • ·Effects of co-application of betamethasone 17-valerate, from different formulations, with tacrolimus ointment on in vitro skin permeation

    Page :P174

    J. Lenn, H. Tanojo, X. Huang

    
• • ·Anatomical region variations on the in vitro skin permeation of clobetasol propionate formulations

    Page :P174

    J. Lenn, H. Tanojo, X. Huang

    
• • ·The use of topical azelaic acid 15% gel or metronidazole 0.75% gel for the treatment of rosacea: evaluation of a single-site comparative trial subset

    Page :P174

    James Q. Del Rosso

    
• • ·The recent economic downturn has had no effect on recently-graduated dermatologists’ workforce choices

    Page :P174

    Josephine C. Nguyen, Alexa Kimball

    
• • ·The use of topical imiquimod for cutaneous epithelial malignancies: clinical experience, optimal application regimens, patient follow-up and tolerability assessments

    Page :P175

    James Q. Del Rosso

    
• • ·A comparison of aminolevulinic acid topical solution and blue light, aminolevulinic acid topical solution and a laser light source or topical 5-fluorouracil in broad area treatment of actinic keratoses of the face and scalp

    Page :P175

    Stacy R Smith, Daniel Piacquadio, Deborah Aiken, Richard Fitzpatrick

    
• • ·A small open-label study of a 2% 4-hydroxyanisole and 0.01% tretinoin solution for the treatment of post-inflammatory hyperpigmentation

    Page :P175

    Valerie D. Callender

    
• • ·Cost-effectiveness analysis of current therapies for melasma

    Page :P175

    Daniel J. Piacquadio, Stacy Smith

    
• • ·An open-label study of the safety and efficacy of triple-combination therapy of melasma in African-American patients

    Page :P176

    Pearl Grimes

    
• • ·Incorporating the use of TNF inhibitors in the management of psoriasis from the perspective of the community dermatologist

    Page :P176

    James Q. Del Rosso

    
• • ·Tuberculosis testing and the use of biologic therapies for the treatment of psoriasis

    Page :P176

    M.Alan Menter, Jennifer Clay Cather, William Abromovits

    
• • ·Retrospective analysis of the treatment of psoriasis of the palms and soles

    Page :P176

    Daniel A. Carrasco, Mark Lebwohl, Suhail Hadi, Phyllis Spuls

    
• • ·Retrospective study of the efficacy of narrowband UVB and acitretin for the treatment of psoriasis

    Page :P177

    Daniel A. Carrasco, Mark Lebwohl, Mariya Rosenblit, Phyllis Spuls

    
• • ·Transition from methotrexate and cyclosporine to other therapies

    Page :P177

    Daniel A. Carrasco, Mark Lebwohl, Mariya Rosenblit, Shira Maryles

    
• • ·Rethinking the PASI: variations on a theme

    Page :P177

    Christine C. Jacobson, Alexa Kimball

    
• • ·Cost-effectiveness of the new biologic modifiers for therapy of psoriasis

    Page :P177

    Stefan C. Weiss, Josephine Nguyen, Alexa Kimball

    
• • ·Assessing the burden of psoriasis

    Page :P178

    Stefan C. Weiss, Alexa Kimball

    
• • ·In vitro human skin study of combined application of pimecrolimus cream and betamethasone 17-valerate

    Page :P178

    H. Deng, H. Tanojo, J. Lenn, C. Cuesico

    
• • ·Impact of vehicle on clobetasol propionate skin permeation and drug distribution in vitro

    Page :P178

    X. Huang, H. Tanojo, J. Lenn, C. Cuesico

    
• • ·Directional association of preclinical, vasoconstrictor assay and clinical results of topical clobetasol formulations

    Page :P178

    X. Huang, H. Tanojo, J.A. Myers

    
• • ·Local tolerabilty of Tisocalcitate ointment in humans

    Page :P179

    Angelika Jahreis, Eugene O’Keefe

    
• • ·Safety of large area application of a novel vitamin D analogue (Tisocalcitate ointment) in patients with chronic plaque type psoriasis

    Page :P179

    Marion Schneider, Thomas Staks, Angelika Jahreis, Eugene O’Keefe

    
• • ·Cost efficacy comparison of biologics in the treatment of psoriasis

    Page :P179

    Lee A. Wanke, Daniel Malone, Chiun-Fang Chiou, Michael Woolley

    
• • ·Alphabetic index to abstract authors

    Page :P180

    Plan Plan
• • ·Subject index

    Page :P188